Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,insulin-like growth factor I binding (GO:0031994),-0.863276703903056,-2.0771447510360046,0.0,0.002117213869285057,0.002,9/13,11.21%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.8545603946622419,2.073165110139994,0.0,0.020849082443166255,0.02,7/23,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.8621055384718447,2.0614914374261124,0.0,0.013267597918378527,0.025,7/21,2.42%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.926017869803009,2.0614643700719273,0.0,0.008845065278919017,0.025,5/12,2.18%,PDE8B;PDE4D;PDE4C;PDE3A;PDE7B
prerank,inward rectifier potassium channel activity (GO:0005242),0.8275789831518983,2.0372119626565115,0.0,0.013978362092577376,0.052,3/24,1.12%,ABCC9;KCNJ8;KCNJ12
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.7236328485420154,-2.0309352153214335,0.0,0.0015879104019637924,0.003,8/25,6.02%,MICAL3;POR;MICAL2;CYP26B1;NOS3;FMO1;FMO2;CYP27A1
prerank,cyclic nucleotide binding (GO:0030551),0.8284720616629923,2.006064643300037,0.0,0.024450287592440428,0.104,7/21,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE5A;SLC19A1;PDE4B;POPDC3
prerank,retinoid binding (GO:0005501),-0.7526555742552992,-2.0018112122768983,0.0,0.0017643448910708806,0.005,7/22,9.70%,ALDH1A2;RBP1;PTGDS;CYP26B1;RBP4;ABCA4;CRABP2
prerank,store-operated calcium channel activity (GO:0015279),0.932769431486769,1.981088609147791,0.0,0.03237925682461426,0.155,4/10,1.23%,TRPC3;TRPC4;TRPC6;TRPC1
prerank,glutamate receptor activity (GO:0008066),0.8421475704789131,1.9716358048856888,0.0020876826722338203,0.03479359862268654,0.187,7/19,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRID1;GRIA2
prerank,cation channel activity (GO:0005261),0.651074486308682,1.9687893613972878,0.0,0.03222130923034785,0.193,17/94,7.60%,ABCC9;TRPC3;ANO1;TRPC6;CACNB2;TRPC1;KCNG1;TRPV2;KCNQ4;UNC80;SLC24A4;SLC24A2;TMEM38B;RYR2;CHRNA7;CACNA1D;TMEM38A
prerank,calcium channel activity (GO:0005262),0.6555932632586076,1.9599046435030976,0.0,0.0344325755500776,0.226,12/84,4.63%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;TRPC1;TRPV2;CACNG7;CACNA2D1;STIM2;SLC24A4;SLC24A2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.9136994230845705,1.9421630663371499,0.0,0.044351684470008215,0.301,7/11,5.55%,TRPC3;TRPC4;TRPC6;TRPC1;ITPR2;ITPR1;RPH3A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.8144689674387011,-1.9108782913316826,0.0,0.01984888002454741,0.069,7/12,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,cAMP binding (GO:0030552),0.870754362669215,1.90582639707938,0.0022026431718061676,0.07538407908169618,0.495,5/11,6.49%,PDE4D;RAPGEF2;RAPGEF4;PDE4B;POPDC3
prerank,glucuronosyltransferase activity (GO:0015020),-0.7242849428365854,-1.895826217395541,0.0,0.02159558146670758,0.09,4/19,5.31%,EXT1;LARGE1;CSGALNACT1;CHSY1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7660036508040282,-1.8879950981030122,0.0,0.021701442160171832,0.106,6/15,12.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6845709247757622,1.887251821870678,0.0,0.09224139505158405,0.596,15/55,7.38%,TRPC3;CACNB2;ATP2A3;TRPC1;ITPR2;TRPV2;ATP2C1;ATP2B3;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7351162343609222,1.872482730619153,0.003745318352059925,0.10482860333312263,0.653,9/31,9.95%,ABCC9;SLC12A2;KCNG1;KCNQ4;SLC12A6;TMEM38B;TMEM38A;PKD2;SLC12A5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.8246883151279223,1.8716629944261287,0.01020408163265306,0.09205185793846435,0.659,2/16,0.25%,ANO1;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.8246883151279223,1.8716629944261287,0.01020408163265306,0.09205185793846435,0.659,2/16,0.25%,ANO1;ANO4
prerank,ion gated channel activity (GO:0022839),0.7555841530288376,1.8182047336867715,0.00808080808080808,0.1703464804163243,0.876,2/24,0.25%,ANO1;ANO4
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6938991443979274,-1.798643870063153,0.0,0.08015166790864858,0.376,9/18,11.59%,TGFBR3;SMAD3;SMAD6;TGFBR2;TGFBR1;SMAD7;FKBP1A;USP15;TGFB1
prerank,I-SMAD binding (GO:0070411),-0.7590286234329178,-1.7919740707193037,0.0018450184501845018,0.07701365449524393,0.41,6/13,6.13%,SMAD3;SMAD6;TGFBR1;SMAD9;SMAD7;SMURF1
prerank,cGMP binding (GO:0030553),0.8371945394664984,1.7862640057857766,0.015217391304347827,0.22699856606570315,0.956,2/11,1.66%,RAPGEF2;PDE5A
prerank,calcium activated cation channel activity (GO:0005227),0.7679980114185397,1.781414660726519,0.013513513513513514,0.22439088225448128,0.961,2/17,2.25%,ANO1;KCNMB1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7544417120311451,-1.7753664863680945,0.0018832391713747645,0.08751150659711569,0.49,6/13,12.86%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,anion channel activity (GO:0005253),0.6144038534082547,1.7573128845058945,0.0035026269702276708,0.2642546382389828,0.979,7/61,5.87%,ANO1;ANO4;SLC1A4;GPR89A;GPR89B;GABRG2;GABRA2
prerank,voltage-gated anion channel activity (GO:0008308),0.7737852215819866,1.7565706619791708,0.030042918454935622,0.2526529717885511,0.979,3/15,4.65%,ANO1;GPR89A;GPR89B
prerank,metalloendopeptidase activity (GO:0004222),-0.5019268799401598,-1.751189132204217,0.002551020408163265,0.10787204664007365,0.581,25/76,16.08%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ADAMTS1;ADAMTS15;ADAMTSL1;ADAMTSL4;MMP14;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.792233472147652,1.7496541042065512,0.021691973969631236,0.25664227674087986,0.982,7/13,7.50%,PIP5K1B;PIK3CD;PIP4K2A;PIK3CA;PIP4K2C;PIK3C2A;PIKFYVE
prerank,potassium channel regulator activity (GO:0015459),0.6408023210360826,1.7437469721297547,0.016129032258064516,0.25910584895794425,0.99,6/49,5.48%,ABCC9;NEDD4L;KCNMB1;KCNE4;DPP10;KCNAB3
prerank,cholesterol transfer activity (GO:0120020),-0.6928493932829582,-1.7394365951453203,0.0038240917782026767,0.11336717900080896,0.624,7/16,17.78%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5
prerank,transforming growth factor beta binding (GO:0050431),-0.6385927097030414,-1.7295294465415338,0.002070393374741201,0.11794645596808838,0.676,13/23,23.75%,TGFBR3;TGFBR2;THBS1;TGFBR1;ACVR1;LTBP4;ACVRL1;TWSG1;LTBP1;CD109;LRRC32;NRROS;LTBP3
prerank,insulin-like growth factor binding (GO:0005520),-0.6953791337846904,-1.727118189899126,0.007326007326007326,0.11261949158543205,0.691,9/15,11.21%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,MAP-kinase scaffold activity (GO:0005078),-0.7575133230416746,-1.7259205510489062,0.0018450184501845018,0.10570946390216106,0.693,4/11,2.79%,AKAP13;SH3RF1;IQGAP1;KSR1
prerank,potassium channel activity (GO:0005267),0.5806332375632303,1.7227614165749732,0.004885993485342019,0.29353530301406405,0.997,18/89,9.02%,ABCC9;KCNG1;KCNMB1;KCNV2;KCNQ4;GRIK1;KCND2;KCNH8;KCNH4;TMEM38B;KCNQ5;HCN2;TMEM38A;KCNE5;KCNA4;KCNQ3;HCN3;PKD2
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7939423664283769,1.7210378884173234,0.05411255411255411,0.2846215648680727,0.997,2/10,0.73%,CACNA1C;CACNB2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.6659396295402633,-1.719092554760429,0.005905511811023622,0.10656643142068119,0.726,7/18,6.10%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,sterol transfer activity (GO:0120015),-0.6678381315712666,-1.7131060821548594,0.007619047619047619,0.10824255906719853,0.749,9/17,24.62%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5;OSBP;GRAMD1B
prerank,voltage-gated chloride channel activity (GO:0005247),0.8197272732416621,1.7126910539305433,0.033112582781456956,0.2913943577102164,0.998,1/10,0.04%,ANO1
prerank,G protein-coupled receptor activity (GO:0004930),0.49804252891015266,1.7116854609401808,0.0026455026455026454,0.28230095021385077,0.998,25/239,6.60%,GRM3;PDGFRB;CYSLTR2;P2RY14;S1PR3;PTH1R;ADGRL3;RORB;ADORA2A;GPR61;GPR152;ADCYAP1R1;FFAR2;GIPR;OPN1MW;OPN1MW3;GRM5;GPR87;XPR1;TAS1R1;GRM1;CXCR2;GPR45;TRHR;OPRK1
prerank,leak channel activity (GO:0022840),-0.6707707126310346,-1.7112455439888483,0.007575757575757576,0.10424164756421132,0.764,3/18,2.80%,KCNK2;NALCN;KCNK5
prerank,diacylglycerol kinase activity (GO:0004143),0.7974181626537735,1.6900124639292637,0.034334763948497854,0.3196508313298234,1.0,3/11,1.88%,DGKB;DGKH;DGKG
prerank,chloride channel activity (GO:0005254),0.6036385881671217,1.689807131269147,0.008944543828264758,0.3088101107328716,1.0,7/59,6.37%,ANO1;ANO4;SLC1A4;TTYH2;GABRG2;GABRA2;TTYH1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6194733178622406,1.6875759373616066,0.02434782608695652,0.30309598692847495,1.0,7/48,4.77%,ABCC9;TRPC6;SLC12A2;TRPC1;TRPV2;UNC80;SLC12A6
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.6567104626838742,1.6857941703168786,0.014925373134328358,0.2973837304847987,1.0,6/34,5.31%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;OGT
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6395580683862275,-1.681866281248718,0.00749063670411985,0.13891275442364734,0.863,7/18,5.49%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BAIAP2;ANXA1;CNN3
prerank,calcium channel regulator activity (GO:0005246),0.6320955208555115,1.6795007226564873,0.023593466424682397,0.3018837083962856,1.0,7/37,3.94%,REM1;PRKG1;RRAD;NRXN1;CACNG7;STIM2;ITPR1
prerank,frizzled binding (GO:0005109),-0.5585727589561632,-1.6790534703225912,0.0022222222222222222,0.13622599764215695,0.87,16/34,17.60%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;WNT5A;FZD7;ZNRF3;MYOC;WNT5B;CCDC88C;WNT16;SFRP1;WNT11;FZD1
prerank,filamin binding (GO:0031005),-0.725504719520008,-1.677168015421142,0.014842300556586271,0.1330668916845658,0.877,3/11,5.34%,NEBL;DPYSL3;SYNPO2
prerank,NAD binding (GO:0051287),-0.5740000419294833,-1.6611382565790198,0.012345679012345678,0.14976767632490245,0.914,11/26,20.04%,ALDH1A1;CRYL1;PARP9;SORD;ME1;NNT;BDH2;SIRT2;SIRT3;HSD17B8;NUDT6
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6671588107512012,1.6598498565908801,0.04046242774566474,0.33660606683100525,1.0,5/27,3.94%,SLC12A2;ATP2A3;ITPR2;ATP2B3;ITPR1
prerank,P-type ion transporter activity (GO:0015662),0.7765630827995706,1.6553692278052752,0.03655913978494624,0.33548069022185706,1.0,5/12,6.59%,ATP2A3;ATP2C1;ATP7A;ATP2B3;ATP2A2
prerank,SH2 domain binding (GO:0042169),0.6558160798763961,1.6513550685761382,0.03409090909090909,0.333836177034495,1.0,4/31,3.86%,DLC1;PTK2;AFAP1L2;PAG1
prerank,chemokine binding (GO:0019956),0.6453117981689336,1.6455103896198215,0.046242774566473986,0.3378905192315217,1.0,8/30,8.21%,ITGA4;CCRL2;ACKR3;FGF2;ITGB1;CXCR2;ACKR2;CCR9
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.3995192813663497,-1.6432620415408565,0.0,0.17255293034673214,0.943,73/254,18.12%,NFIB;SMAD3;ZBTB16;MECOM;NFAT5;FOXO1;FOXO3;NFIA;NR3C1;ERG;HOXB3;MLXIP;ESR1;ELF1;ELF4;MEOX2;KLF4;PLAGL1;TCF4;FOXC2;TFDP2;NFATC1;LEF1;HOXA5;AR;PRRX1;GLIS2;GTF2I;IRF1;SIX1;HLF;PRDM16;FOXC1;IRF2;STAT3;HINFP;NR2C2;PGR;KLF10;TFCP2;RREB1;HIF1A;NR4A2;ATF6;FOSL2;TFCP2L1;CEBPG;NFYC;ELK3;MDM2;ZIC3;RELA;PPARA;MEF2A;CLOCK;MEIS2;ZNF585A;ZNF585B;SOX17;HSF2;CREB3L1;HOXC4;HOXB7;CREB3;NKRF;HHEX;MEIS1;SOX18;ATF1;NFYB;MAFF;SOX12;KLF15
prerank,semaphorin receptor activity (GO:0017154),-0.7261149421476356,-1.6378547594385278,0.018315018315018316,0.1747161706044799,0.95,4/11,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.6307348840636978,-1.6307690689473433,0.007874015748031496,0.18027193924516724,0.962,5/18,16.30%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2
prerank,phospholipase C activity (GO:0004629),0.6753421690859934,1.6285779396240303,0.04158790170132325,0.36556970692960833,1.0,3/25,0.48%,PLCL1;EDNRA;PLCE1
prerank,LRR domain binding (GO:0030275),-0.6737211131048537,-1.6226234473135421,0.01845018450184502,0.18783921448297022,0.97,4/14,9.13%,ROBO1;PAWR;ERC1;PMF1
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.4982617969644548,-1.6200130989195227,0.009111617312072893,0.1853783605164397,0.972,19/53,18.74%,MICAL3;AOX1;POR;DDO;MICAL2;XDH;NOS3;DPYD;PRODH;AIFM1;ACOX1;ACADL;PPOX;ACOX3;NOS1;SQOR;ILVBL;QSOX1;CYB5R3
prerank,phosphatidic acid binding (GO:0070300),0.6815498978252328,1.6124527649891256,0.06639004149377593,0.39372493282107085,1.0,3/19,1.89%,PITPNC1;RAPGEF2;MARK1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.45562023122364903,-1.6032415097172306,0.005319148936170213,0.21148614094302956,0.981,27/78,15.97%,CTSH;CASP12;USP47;CAPN2;CTSC;CFLAR;USP46;CASP4;USP12;USP8;CAPNS1;USP15;USP18;CTSB;CAPN5;CAPN1;USP34;CASP8;USP35;USP11;USP5;GPAA1;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5887225488983707,-1.6025967431206838,0.01768172888015717,0.20544536010169642,0.981,8/24,10.41%,PLA2G4A;OSBPL8;CERT1;SESTD1;ARFIP2;GOLPH3;DAB2IP;GSDMD
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7614508329867795,1.593565247206903,0.04430379746835443,0.4279548501492021,1.0,4/11,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,wide pore channel activity (GO:0022829),0.6781327048802446,1.5927825492866206,0.046747967479674794,0.4191200162933934,1.0,4/23,6.35%,GJD3;GJC1;GJA4;GJC2
prerank,ion channel activity (GO:0005216),0.545423079484985,1.5910557566456285,0.02159468438538206,0.4120536839222131,1.0,10/80,6.61%,ABCC9;TRPC6;TRPC1;TRPV2;CHRNA3;UNC80;GRIK1;GRID1;GRIA2;CHRNA7
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6862611343601043,-1.5857966366420224,0.022944550669216062,0.23117785231348734,0.989,7/12,13.97%,SULF1;ARSB;SULF2;ARSI;ARSK;ARSG;GALNS
prerank,carboxylic acid binding (GO:0031406),0.6084103742045174,1.5830770346184062,0.04805914972273567,0.4205874768690168,1.0,3/38,2.38%,GRM7;UBR1;SESN3
prerank,GTPase regulator activity (GO:0030695),0.4731590412035362,1.5812582546589062,0.010810810810810811,0.41499602196397595,1.0,31/212,5.01%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RGS6;TBC1D1;ARHGAP10;RAPGEF2;ARHGAP32;ARHGEF6;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;WAS;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;WASL;RIMS1;RGS11;RTKN;ASAP2;TBC1D30;RIN2;SYDE1
prerank,gap junction channel activity (GO:0005243),0.6809627435122183,1.5799492996531772,0.04918032786885246,0.40832024357773916,1.0,4/22,6.35%,GJD3;GJC1;GJA4;GJC2
prerank,solute:anion antiporter activity (GO:0140323),-0.6378470444546169,-1.5748210404140344,0.03313840155945419,0.24697299785210186,0.994,3/14,2.95%,SLC7A11;SLC26A7;SLC26A2
prerank,exopeptidase activity (GO:0008238),0.5833514171990672,1.5686946481976336,0.0498220640569395,0.42320621996464236,1.0,9/50,5.28%,ACE2;ENPEP;FAP;NAALAD2;CPM;METAP2;ANPEP;GGH;DPP10
prerank,GTPase activator activity (GO:0005096),0.4476887131654949,1.5678705388260838,0.003816793893129771,0.4154653519583676,1.0,39/313,5.01%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RAPGEF5;RGS6;TBC1D1;PLCE1;ARHGEF17;ARHGAP10;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;ARHGAP32;FARP1;ARHGEF6;RASGRP2;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;RGS11;RALGPS1;CYTH3;ASAP2;EPS8L1;TBC1D30;RIN2;SYDE1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.7008705288294543,1.5634146593023843,0.07158351409978309,0.41737308420563757,1.0,4/14,9.40%,PTEN;MTMR12;MTMR14;MTMR7
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6290556925972729,1.5626406453687043,0.0622568093385214,0.4102671958134466,1.0,11/28,14.69%,CHRNA3;GRIK1;GABRG2;GRID1;GABRA2;CHRNA7;GABRA5;GABRA4;GRIK5;GRIK2;CHRNB2
prerank,phospholipase inhibitor activity (GO:0004859),-0.7040935812402536,-1.555253341449732,0.026022304832713755,0.2831944293222738,0.997,4/10,3.96%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5232835095988584,1.5505247960623842,0.03522205206738132,0.4295779695060714,1.0,9/73,8.13%,EDNRA;CYSLTR2;PTH1R;ADCYAP1R1;GIPR;SORCS1;NPSR1;OPRK1;GPR37
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6156470337106115,1.5442595090662738,0.06954887218045112,0.4346202046965047,1.0,4/27,5.36%,ANO1;XPR1;SLC22A8;SLC26A1
prerank,R-SMAD binding (GO:0070412),-0.5799211812979872,-1.5252479376732198,0.0398406374501992,0.3522845389690089,1.0,5/18,6.13%,LDLRAD4;SMAD3;SMAD6;DDX5;SMURF1
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5957786587981778,-1.524298866454179,0.04462474645030426,0.3339904878797177,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,ephrin receptor activity (GO:0005003),-0.5957786587981778,-1.524298866454179,0.04462474645030426,0.3339904878797177,1.0,6/17,12.29%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,bHLH transcription factor binding (GO:0043425),-0.5871350701180915,-1.5233692377442898,0.04225352112676056,0.3273817560163065,1.0,7/19,16.67%,SMAD3;FHL2;BHLHE40;LMO2;BHLHE41;USF1;USF2
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6687349560757521,-1.515569823652536,0.03925233644859813,0.3384601616037639,1.0,4/11,8.73%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,potassium ion leak channel activity (GO:0022841),-0.627312545114142,-1.5144415037900445,0.04823747680890538,0.33171591352014795,1.0,2/15,2.80%,KCNK2;KCNK5
prerank,FAD binding (GO:0071949),-0.5525667168801386,-1.5050481037557888,0.023575638506876228,0.34663805494097316,1.0,8/24,18.74%,MICAL3;DDO;MICAL2;PRODH;AIFM1;SQOR;QSOX1;CYB5R3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.6490077855904548,1.4979897136355955,0.09533898305084745,0.5388161051766639,1.0,4/16,9.40%,PTEN;MTMR12;MTMR14;MTMR7
prerank,leucine zipper domain binding (GO:0043522),-0.6787339464776578,-1.4880712169767114,0.036297640653357534,0.38378572945924894,1.0,3/10,9.13%,PAWR;ERC1;PMF1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.5350858731650309,-1.4866111538042808,0.0408997955010225,0.37797560601411473,1.0,7/24,14.99%,DAPK1;CAMK1D;PHKA2;PTK2B;CAMK2A;MKNK2;MAPKAPK3
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.5271784904658654,-1.4849540914446286,0.036170212765957444,0.37337841175281955,1.0,13/29,20.55%,PTPRJ;NFATC1;ACE;MAPK14;DUSP1;DUSP16;GCH1;DUSP7;MAPKAPK3;DUSP10;TPR;ATF7;CDK5RAP3
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6182076473317216,1.4833882012053672,0.09876543209876543,0.5653594771241829,1.0,7/21,16.17%,CHRNA3;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNB2;GRIA1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6263895328016433,1.4778048220951645,0.09236947791164658,0.5700328677074773,1.0,8/19,12.33%,GRIK1;GABRG2;GRID1;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6614240088339246,-1.4753464317096414,0.05639097744360902,0.39188620523385786,1.0,3/10,8.73%,SLC6A13;SLC6A12;SLC6A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.5466643509736098,-1.4750302852868422,0.05870841487279843,0.3836342293612679,1.0,13/22,31.43%,DUSP1;DUSP12;DUSP16;DUSP7;DUSP10;DUSP23;MTMR3;DUSP15;PPM1F;DUSP8;DUSP4;CDKN3;DUSP18
prerank,muscle alpha-actinin binding (GO:0051371),-0.5918831393123646,-1.4650978278564568,0.06153846153846154,0.4025352868978215,1.0,5/15,5.99%,PDLIM5;PALLD;SYNPO2;PDLIM7;PDLIM2
prerank,C-C chemokine receptor activity (GO:0016493),0.613630661285214,1.4645650626273312,0.1191919191919192,0.5941094453315969,1.0,5/21,8.21%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,voltage-gated calcium channel activity (GO:0005245),0.5569218775187937,1.463293479335566,0.09357798165137615,0.5866349148381469,1.0,8/37,9.86%,CACNA1C;CACNB2;CACNA1H;CACNG7;CACNA2D1;CACNA1D;PKD2;CACNA1A
prerank,nucleotide diphosphatase activity (GO:0004551),-0.6103231572009187,-1.4625943703066038,0.06433823529411764,0.3999652245064948,1.0,8/14,20.86%,ENPP1;FHIT;NUDT4;NUDT3;NUDT12;NUDT13;NUDT6;CILP
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.6098648790657095,-1.461599158142038,0.07854406130268199,0.39433108315434184,1.0,7/12,18.39%,TAF1;STAT1;H3-3A;HDAC1;RELA;POU2F1;TBPL1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.6007437076274983,-1.4612068430182752,0.04940711462450593,0.38693209638774456,1.0,6/14,23.71%,CAPN2;CAPNS1;CAPN5;CAPN1;CAPN6;CAPN15
prerank,cytochrome-c oxidase activity (GO:0004129),0.6603144402426805,1.4609371092344492,0.1062124248496994,0.5827749309031149,1.0,2/15,1.21%,COX4I2;NDUFA4L2
prerank,poly(A) binding (GO:0008143),0.6247578124539579,1.4592728599542961,0.10323886639676114,0.5764974371013812,1.0,9/21,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;HNRNPU
prerank,chloride channel inhibitor activity (GO:0019869),-0.6519953048880505,-1.4569201746701148,0.0687732342007435,0.39049363301626266,1.0,4/10,10.33%,WNK4;STX7;WNK1;STX1A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6182065319515747,-1.4546065932844567,0.07212475633528265,0.3887679956916795,1.0,6/12,11.21%,CDH5;ITGA5;VEGFD;VEGFC;DAB2IP;ITGB3
prerank,voltage-gated potassium channel activity (GO:0005249),0.4896390277165649,1.4533620924947053,0.07511737089201878,0.5822280845910998,1.0,21/80,12.95%,KCNJ8;KCNJ12;KCNG1;KCNV2;KCNQ4;KCNE4;KCND2;KCNH8;KCNH4;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;KCNJ3;KCNJ6;KCNC4;KCNG2;KCNMA1
prerank,voltage-gated cation channel activity (GO:0022843),0.4786969098774179,1.4530531319182896,0.04489164086687306,0.5729903002483967,1.0,20/97,9.86%,CACNA1C;CACNB2;KCNG1;KCNV2;KCNQ4;CACNG7;CACNA2D1;KCND2;KCNH8;KCNH4;KCNQ5;HCN2;CACNA1D;KCNE5;KCNA4;KCNQ3;HCN3;PKD2;GRIN2B;CACNA1A
prerank,adrenergic receptor binding (GO:0031690),0.6285977869668955,1.4478352671742516,0.12678936605316973,0.5772368842527471,1.0,3/16,6.00%,PDE4D;RAPGEF2;UCHL1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5995528027860513,1.447816760719689,0.10650887573964497,0.5676636537934813,1.0,2/25,0.90%,ART3;PARP8
prerank,AMP binding (GO:0016208),-0.6483943762754478,-1.4369063926059726,0.08637236084452975,0.43074716170604477,1.0,2/11,3.00%,PRKAG2;MPPED2
prerank,amino acid binding (GO:0016597),0.5768099476609542,1.4315206743584552,0.07884615384615384,0.5997606763922753,1.0,1/31,0.09%,GRM7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.608556188507668,1.4313844989512112,0.13701431492842536,0.5903622516146704,1.0,4/19,4.09%,AFAP1L2;NRG1;GRM5;NRG3
prerank,C-C chemokine binding (GO:0019957),0.5872326675961961,1.4308405053915227,0.13163064833005894,0.5821647472099403,1.0,5/22,8.21%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6198483250727045,-1.4301934209943246,0.08317929759704251,0.44143909174593426,1.0,4/11,19.48%,SLC25A20;SLC22A4;SLC22A5;SLC25A29
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6147978703127348,-1.4273073526423117,0.05952380952380952,0.4412151556636061,1.0,4/13,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,alpha-tubulin binding (GO:0043014),0.5600113553562274,1.426034503144323,0.11338289962825279,0.5850181457135032,1.0,3/31,6.29%,DLEC1;ARL4C;SNCA
prerank,phosphatidylglycerol binding (GO:1901611),0.648894658322193,1.424530896229743,0.14660831509846828,0.5796919705876157,1.0,1/13,0.15%,PITPNC1
prerank,death domain binding (GO:0070513),-0.6276959170666138,-1.4242006780213916,0.07905138339920949,0.4407599854105032,1.0,9/11,30.76%,DAP;MCL1;IRGM;DAPL1;RIPK1;BCL2L1;RACK1;CRADD;TRADD
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.4807607811348103,-1.4206164049906869,0.06318082788671024,0.4432230404691282,1.0,15/35,22.86%,FOXP1;NR3C1;TAF1;STAT1;H3-3A;KLF10;HDAC1;RELA;POU2F1;PARK7;TBPL1;AGO1;UBTF;PIH1D1;SMARCA4
prerank,sodium channel activity (GO:0005272),0.5290665618317695,1.4200052259485938,0.10420475319926874,0.5816779130665737,1.0,14/37,13.64%,CACNA1H;GRIK1;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SCN9A;PKD2;ASIC3;GRIK5;GRIK2;SCN1A
prerank,beta-tubulin binding (GO:0048487),0.558671927815301,1.4169935651094574,0.0967741935483871,0.5797855422967333,1.0,3/31,6.72%,DLEC1;FGF13;APPL1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6540821089037627,1.4151802607362027,0.13978494623655913,0.5757050445486329,1.0,4/14,9.41%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,adenyl ribonucleotide binding (GO:0032559),0.3972475087678528,1.414786631714212,0.024081115335868188,0.5683091787439613,1.0,48/291,10.41%,MYO1B;PDE4D;KCNJ8;MAP3K20;RAPGEF2;CDK6;RAPGEF4;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;SLC19A1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;PDE4B;SYN1;POPDC3;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MYO6;MARK2;MAP4K4;GCK;MAP4K1;COQ8A;NEK6;ABCF3;DARS2;DYRK3
prerank,BMP receptor binding (GO:0070700),-0.6147998883082729,-1.413464599053024,0.076171875,0.45495076571173537,1.0,4/12,3.24%,BMP6;CDH5;BMP7;BMP4
prerank,voltage-gated sodium channel activity (GO:0005248),0.5938383396803311,1.4118191766486285,0.12836438923395446,0.5669596588018938,1.0,10/22,13.64%,CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;HCN3;SCN9A;PKD2;SCN2B;SCN1A
prerank,purinergic nucleotide receptor activity (GO:0001614),0.6093321256681727,1.40880794316806,0.13429752066115702,0.5663021900231848,1.0,2/15,4.03%,P2RY14;GPR87
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6030618114524617,-1.4059549659480755,0.07858546168958742,0.4685469907508877,1.0,2/14,1.30%,SLC7A11;SLC1A3
prerank,vinculin binding (GO:0017166),0.6606835066289255,1.40271770561197,0.14782608695652175,0.5738367722693934,1.0,3/11,3.97%,UTRN;DMD;CORO2B
prerank,phosphoric diester hydrolase activity (GO:0008081),0.533314920563452,1.4023889352553705,0.12022900763358779,0.56676789620408,1.0,4/35,4.62%,PLCL1;PLCE1;PLD6;GPCPD1
prerank,voltage-gated ion channel activity (GO:0005244),0.6264417128093582,1.4012735165838859,0.1504424778761062,0.5618110550978258,1.0,5/14,9.02%,CACNA1H;KCND2;GPR89A;GPR89B;PKD2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6127968957488334,-1.3995708630659955,0.0912621359223301,0.4799203824227645,1.0,5/11,15.97%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,lysophospholipase activity (GO:0004622),-0.5306727326445151,-1.3994643406136016,0.08349900596421471,0.47188316703875743,1.0,11/20,24.87%,PLA2G4A;ASPG;PNPLA7;PLA2G6;LYPLA1;MGLL;ABHD16A;LYPLAL1;ENPP2;GDPD3;LYPLA2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6411763733547542,1.3985005644727597,0.15732758620689655,0.5602337989591892,1.0,3/10,7.15%,PIK3CD;PIK3CA;PIK3C2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.42121192344883324,-1.3904305418895249,0.07444168734491315,0.490170895720326,1.0,20/54,19.40%,HDAC4;HDAC8;TGM2;HDAC9;ACER2;ASPA;NAAA;ACER3;UPB1;ASPG;GLS;ASRGL1;HINT1;HDAC1;HDAC5;NIT2;SIRT7;SIRT2;NIT1;NGLY1
prerank,carboxypeptidase activity (GO:0004180),0.5410010805650984,1.3900211910151443,0.13076923076923078,0.5723147947930632,1.0,3/35,0.96%,ACE2;NAALAD2;CPM
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6615512184605835,1.3895065515821434,0.17488789237668162,0.5659898195477489,1.0,4/10,11.93%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,phosphatidylinositol kinase activity (GO:0052742),0.6073779100956113,1.377577369941283,0.14760914760914762,0.5864108182514098,1.0,4/15,7.50%,PIK3CD;PIK3CA;PIK3C2A;PIKFYVE
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3079683823107975,-1.3772035744034357,0.0,0.5222990181037128,1.0,173/731,16.16%,NFIB;FOXP2;PBX1;PKNOX2;FOXN3;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;HMGB2;SOX18;KDM6B
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5452020027199777,1.3766187791158506,0.13793103448275862,0.5812791362865731,1.0,14/32,20.95%,KCNG1;KCNQ4;KCNE4;KCNQ5;KCNE5;KCNA4;KCNQ3;KCNC4;KCNG2;KCNS3;KCNH1;KCNC2;KCNC1;KCNB2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6134503950154291,-1.3758031632812977,0.10775047258979206,0.5178843957967595,1.0,5/10,15.97%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,triglyceride lipase activity (GO:0004806),0.5907622761654192,1.3754880146374455,0.1649048625792812,0.5766311284579568,1.0,3/20,6.95%,CEL;LIPH;LIPC
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6252849025310148,-1.3742885070630322,0.11641221374045801,0.5142439299607043,1.0,6/10,23.46%,CXADR;CD47;CD200;SIRPA;DSG2;DSP
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5738526911031608,1.3719415182934565,0.12704918032786885,0.5775734028559738,1.0,2/25,3.21%,ADAP2;NCF1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.30589890424438426,-1.3702488628290113,0.0,0.5179444468797031,1.0,174/730,16.16%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;NFATC1;LEF1;KLF2;TRIM24;THRB;MXI1;HOXA5;CREB3L2;SKI;ZNF23;HOXA3;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;TFCP2;IRF9;ZBTB18;FOXL1;RREB1;HIF1A;MKX;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;AHR;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;CREB3L1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B
prerank,protease binding (GO:0002020),-0.37643521823513826,-1.367518293376084,0.020114942528735632,0.5181219315741025,1.0,25/99,11.49%,TIMP3;COL1A2;FN1;COL3A1;COL1A1;VWF;LCOR;CCBE1;F3;SLC2A13;DPP4;ANXA2;TIMP2;CFLAR;ITGA3;RNF139;BDKRB2;AMFR;CST3;ADAMTSL4;ECM1;PSAP;BRCA2;ITGB3;ATP9A
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6124016804089937,1.3659229381858402,0.15490196078431373,0.584594865422771,1.0,7/13,10.18%,PRKAR1B;PKIA;PRKAR2B;RYR2;PRKAR2A;CSK;PRKAR1A
prerank,sequence-specific mRNA binding (GO:1990825),0.6704006727871408,1.3642477464226062,0.16517857142857142,0.5811367738827125,1.0,5/10,16.84%,RBM24;DHFR;SSB;LARP6;FMR1
prerank,death receptor activity (GO:0005035),-0.5984972304327145,-1.3589553134978622,0.11685823754789272,0.5366159983005641,1.0,9/11,35.83%,TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;EDA2R;FAS;TNFRSF14;TNFRSF10B;TNFRSF25
prerank,GTPase inhibitor activity (GO:0005095),-0.5704721530088666,-1.3570836810103168,0.12810707456978968,0.53440402800636,1.0,6/13,20.36%,IQGAP1;SLIT2;CPEB2;IQGAP2;RHOH;PDE6D
prerank,Tat protein binding (GO:0030957),-0.6006121146826511,-1.3568472984339128,0.14684014869888476,0.5272494538659876,1.0,6/10,27.16%,MDFIC;ACTB;GABARAPL1;SMARCA4;DLL1;CTDP1
prerank,mannosyltransferase activity (GO:0000030),-0.5151982552935256,-1.3549493326619668,0.12180746561886051,0.5248666588451889,1.0,3/21,4.87%,TMTC1;TMTC4;TMTC2
prerank,neuropeptide receptor binding (GO:0071855),0.6015859051455669,1.3532444861193924,0.1759465478841871,0.5987454839509071,1.0,2/14,3.63%,UCN2;NMU
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5728169715054678,1.3493737147753904,0.15922330097087378,0.6003197834598096,1.0,2/23,0.48%,EDNRA;PLCE1
prerank,poly-purine tract binding (GO:0070717),0.5460364049172932,1.3452707891885685,0.1442125237191651,0.603014529310224,1.0,10/27,13.28%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;DAZAP1;HNRNPU
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6217979847759437,1.3429286701546084,0.17391304347826086,0.6013337237160657,1.0,4/11,16.92%,SLC5A1;SLC2A9;SLC23A2;SLC23A1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.615417603951754,1.3428611593575697,0.18801652892561985,0.594640384950574,1.0,4/12,12.24%,OPN1MW;OPN1MW3;RRH;OPN3
prerank,tropomyosin binding (GO:0005523),0.592662995632611,1.340565436092276,0.19791666666666666,0.5930488491686131,1.0,4/16,5.35%,CALD1;SMTNL2;TMOD1;TMOD3
prerank,cAMP response element binding (GO:0035497),-0.6185534997544819,-1.3398207005418967,0.13430127041742287,0.5632402577477754,1.0,7/10,28.98%,CREB5;CREB3L2;CREB3L1;ATF7;NR4A3;ATF2;JUN
prerank,ligand-gated ion channel activity (GO:0015276),0.5292624620074426,1.3385247091305792,0.16789667896678967,0.5907977114337016,1.0,14/30,22.14%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,syntaxin-1 binding (GO:0017075),-0.4891528242749402,-1.3367548162047864,0.1254681647940075,0.564857537369044,1.0,3/22,3.94%,DAPK1;UNC13B;LRRK2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3965107412659289,-1.3349526097587963,0.09429280397022333,0.56231411173392,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;NRP2;EPHA7;PDGFRA;NRP1;NTRK3;TEK;FGFR2;EPHB4;IGF1R;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,ligand-gated channel activity (GO:0022834),0.5349942201328481,1.3344545208285215,0.166044776119403,0.5931782651749784,1.0,14/29,22.14%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;GRIA4;GRID2;GRIN1;CNGB1
prerank,peptidase inhibitor activity (GO:0030414),-0.4549582875832302,-1.3335679906125284,0.11320754716981132,0.5586945126316866,1.0,6/33,7.95%,RECK;CAST;TIMP2;ITIH2;SERPIND1;CST3
prerank,low-density lipoprotein particle binding (GO:0030169),0.5735004348029299,1.3284047848534017,0.18816067653276955,0.5998128565134032,1.0,6/16,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,sialyltransferase activity (GO:0008373),-0.5073391640592733,-1.3278609744143945,0.1206896551724138,0.5685299297624703,1.0,9/20,11.77%,ST3GAL4;ST3GAL6;ST3GAL1;ST3GAL2;ST6GALNAC3;ST3GAL3;ST6GALNAC2;ST8SIA2;ST6GALNAC6
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.3951301944393576,-1.3255906682175749,0.07888040712468193,0.5676422049542639,1.0,24/60,13.68%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;TEK;TGFBR2;FGFR2;EPHB4;IGF1R;ACVR1;ACVRL1;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;RET
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5013800738015013,1.325017833138212,0.17702448210922786,0.6000480057017815,1.0,4/38,5.05%,SERPINI1;SERPINB8;WFDC3;SERPINA10
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4913310093460805,1.3211726178873158,0.16225749559082892,0.6023045857445061,1.0,4/55,3.11%,SLC38A11;SLC16A12;SLC16A3;SLC19A1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.40771509730798744,-1.3180900448966892,0.09090909090909091,0.5818527155569193,1.0,20/53,22.34%,SLC7A11;SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A7;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC17A6;SLC25A22;SLC66A1;SLC7A1;SLC22A2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,lipoprotein particle binding (GO:0071813),0.5514965126055684,1.3180308405678158,0.17901234567901234,0.6026083120702331,1.0,6/20,6.95%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5705618512336834,1.3150860380589158,0.19301848049281314,0.5970907560984563,1.0,1/16,0.16%,PTPRK
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5705618512336834,1.3150860380589158,0.19301848049281314,0.5970907560984563,1.0,1/16,0.16%,PTPRK
prerank,G protein-coupled receptor binding (GO:0001664),-0.3435543001738335,-1.3135920339663605,0.05448717948717949,0.5885715266226321,1.0,40/132,22.30%,WNT4;WNT6;LRP6;WNT9A;RNF43;SDCBP;CXCL12;ARRB1;PDCD6IP;ACE;WNT5A;ITGB4;GNAS;TULP3;FZD7;GNA14;ZNRF3;MYOC;PTCH1;GRK2;CCL25;WNT5B;S1PR1;CCDC88C;WNT16;SFRP1;REEP1;HOMER1;GNA13;HOMER3;WNT11;FZD1;PPY;AGTR1;TAFA5;NTS;BAMBI;GNAI1;REEP2;CCL19
prerank,protein tyrosine kinase binding (GO:1990782),-0.37852979846976703,-1.3121456941140541,0.0688836104513064,0.58539588671531,1.0,10/71,5.09%,EPHA4;CDH5;PTPN14;TJP2;DOCK4;NEDD9;BMPR2;ANGPT1;ACVR1;GAS6
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.4105324598725382,1.311763801232174,0.10105580693815988,0.597602781457694,1.0,16/147,4.79%,RAPGEF5;PLCE1;ARHGEF17;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;FARP1;ARHGEF6;RASGRP2;PREX2;RALGPS1;CYTH3;EPS8L1;RIN2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6153650985815713,1.3077726686527948,0.1956989247311828,0.6004306001676585,1.0,3/10,9.60%,APOBEC1;ADARB2;DCTD
prerank,serine-type peptidase activity (GO:0008236),0.4269510268040115,1.3075988779727485,0.109717868338558,0.5949285675157491,1.0,6/96,3.05%,TMPRSS4;FAP;NAALAD2;TMPRSS7;RHBDD3;RHBDF1
prerank,adenylate cyclase binding (GO:0008179),0.6105291062126575,1.3075169363189416,0.2073170731707317,0.5892446122180008,1.0,4/10,8.29%,CAP2;AKAP6;CAP1;AKAP12
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4501534016285068,1.30559658690224,0.14720812182741116,0.5873513568670414,1.0,20/74,15.48%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;ADK;CLP1;PIK3C2A;XYLB;GK;NMRK1;DGKD;COASY;CHKB;PAPSS1;FAM20A;IPMK;FCSK;DGKI;IPPK
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5696136350801525,-1.3031824421577907,0.16296296296296298,0.6059710387801827,1.0,5/11,25.14%,LEF1;SRRM2;GATA2;MBD2;ZXDC
prerank,actin monomer binding (GO:0003785),-0.4877291907437526,-1.3031460898947018,0.15876288659793814,0.598461320355316,1.0,7/22,13.17%,MTSS1;LIMA1;NOS3;PRKCE;TMSB4X;PFN1;TWF1
prerank,phospholipase activator activity (GO:0016004),0.6327434289731989,1.3028301536844058,0.21473684210526317,0.5874546407022414,1.0,3/10,12.52%,ARHGAP6;STX4;SRC
prerank,iron ion binding (GO:0005506),-0.4073229853947428,-1.3027854363048705,0.12359550561797752,0.5919333000920528,1.0,25/48,35.96%,KDM7A;AOX1;AGMO;EGLN2;EGLN3;FTL;KDM3A;DNAJC24;FTO;ISCA2;TYW5;FTH1;DOHH;TET2;EGLN1;CYP2R1;CDO1;TET1;HIF1AN;ACP5;RIOX1;JMJD6;HAAO;ALOX5;PHYH
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5647209293270712,-1.302562876618761,0.1792452830188679,0.5853573579716568,1.0,5/11,18.66%,SGMS1;SGMS2;PTDSS2;PIGN;PTDSS1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.46267272339322546,-1.3019816913596227,0.13552361396303902,0.5796647557607825,1.0,10/26,9.26%,SLC6A13;SLC16A2;SLC6A6;SLC6A12;ABCG2;SLC16A1;SLC16A6;SLC16A11;SLC6A1;SLC5A6
prerank,metalloexopeptidase activity (GO:0008235),0.482314513579472,1.3014969338578546,0.15827338129496402,0.5848769041147841,1.0,6/51,3.20%,ACE2;ENPEP;CPM;METAP2;MMP15;ANPEP
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.2843301750371898,-1.299172380473821,0.0,0.5814302931270956,1.0,197/830,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;AEBP1;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;CUX1;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;OSR1;KLF3;SKIL;FOXO3;ZIC2;NFIA;NR3C1;HIVEP3;ERG;HOXB3;RARB;MLXIP;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;NFATC1;LEF1;KLF2;ETV6;TAF1;THRB;MXI1;HOXA5;SKI;ZNF23;HOXA3;GTF2IRD1;TEAD4;ARNT2;AR;RARG;CREM;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;IRF1;TEAD1;SIX1;HLF;HOXC6;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;H3-3A;KLF10;ZNF219;TBX1;ZBTB8A;TFCP2;IRF9;ZBTB18;FOXL1;LHX6;RREB1;HIF1A;MKX;TWIST2;NLRC5;FOXK1;NR4A2;ATF6;BHLHE41;FOSL2;IKZF1;HOXB9;TFCP2L1;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;ZFHX2;KLF12;SIX5;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;GLI3;FOXQ1;NSD1;ELK3;HDAC1;LRRFIP1;ZSCAN22;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;GATA6;ATOH8;ZGPAT;CLOCK;MEIS2;ZNF585A;ZNF585B;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;ENO1;POU2F1;MAZ;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;NKX6-1;SNAI1;CREB3;JUND;SREBF1;NKRF;HHEX;MEIS1;SOX18;KDM6B;MNT;USF2;ZFP69;ZNF436;JUNB;ATF1;NFIL3;NFYB;ZFP14;NFXL1;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15
prerank,FMN binding (GO:0010181),-0.5755815699665836,-1.2989213324679874,0.15514018691588785,0.5753780739052294,1.0,2/11,3.16%,POR;NOS3
prerank,SH3 domain binding (GO:0017124),0.44857383614542484,1.296364832656968,0.14669051878354203,0.5901824679474639,1.0,8/62,3.65%,SGIP1;AFAP1L2;VASP;WAS;PTPN22;WIPF1;NCF1;ABI2
prerank,"DNA binding, bending (GO:0008301)",-0.54455708783568,-1.295219284380177,0.1689059500959693,0.5794440734256268,1.0,6/14,16.14%,FOXD1;LEF1;FOXC1;FOXL1;HHEX;HMGB2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.571463861631856,1.2932066555291175,0.19957983193277312,0.5911948651958884,1.0,1/15,0.22%,NDST3
prerank,metallopeptidase activity (GO:0008237),-0.3483352456038021,-1.290254844290644,0.06744868035190615,0.5863205291964292,1.0,32/113,16.08%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;PAPPA;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ACE;ADAMTS1;ADAMTS15;ADAMTSL1;RNPEP;ERAP1;LNPEP;ADAMTSL4;MMP14;ADAM15;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;MPND;ADAM33;MMP2;AFG3L2;ADAMTSL5
prerank,sequence-specific DNA binding (GO:0043565),-0.2846936197392695,-1.2866853231551587,0.0,0.5895467194294844,1.0,130/590,18.12%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;FLI1;NFAT5;FOXP1;HDAC4;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;FOXO1;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;FOXD1;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;TAF1;THRB;HOXA5;ZNF23;ARNT2;RARG;CREM;GLIS2;SOX13;BHLHE40;TEAD1;SIX1;HLF;KDM5B;TET3;PRDM16;FOXC1;IRF2;GLIS1;HIVEP1;BPTF;NR2C2;KLF10;TBX1;SMG6;TFCP2;IRF9;ZBTB18;VSX1;FOXL1;LHX6;UPF3A;HIF1A;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;ZKSCAN3;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;PPARA;MEF2A;USF1;GATA6;ZGPAT;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;SLTM;POU2F1;ZBTB4;HOXC4;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;SOX18;CENPB;USF2;JUNB;MYRF;SMG5;FBXL19;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CEBPB;KLF15
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3967915493019097,-1.2866135098626024,0.1091703056768559,0.5830758877514017,1.0,17/51,16.02%,SLCO2B1;SLC16A2;MCU;SLCO2A1;ANKH;SLCO1C1;SLC20A2;SLC22A6;TMEM241;SLC22A4;SLC7A5;SLC5A6;CLCN3;SLC5A5;MFSD2A;SLC35D2;SLC35E4
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6391023170832418,1.2815401811347462,0.21902654867256638,0.6108852010843272,1.0,3/10,5.28%,FAP;NAALAD2;DPP10
prerank,MAP kinase activity (GO:0004707),-0.5236791949235606,-1.2812844167186488,0.18269230769230768,0.592451155141682,1.0,4/14,14.52%,MAPK4;MAPK14;MAPK6;MAPK3
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5832315528766706,-1.2804727299048924,0.18148820326678766,0.5886677917561624,1.0,7/10,28.90%,USP15;IDE;DNAJB2;ANKRD13D;ANKRD13A;DNAJC2;LAPTM5
prerank,metallocarboxypeptidase activity (GO:0004181),0.5200783342954648,1.2802238949422473,0.1926070038910506,0.6083000598516896,1.0,2/26,0.96%,ACE2;CPM
prerank,titin binding (GO:0031432),-0.5197944060036347,-1.2785428423977043,0.16923076923076924,0.58802706958583,1.0,4/13,16.17%,ACTN2;CALM2;TRIM63;CALM1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5956975635237961,1.2719587482894763,0.21460176991150443,0.6209340158156997,1.0,6/12,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5566535661370702,-1.2711123212708175,0.17790262172284643,0.6036706044799018,1.0,7/12,32.81%,ENTPD1;ENTPD5;CANT1;ENTPD2;NUDT18;ENTPD3;NUDT5
prerank,phospholipase binding (GO:0043274),0.5862139260490813,1.270318819030625,0.22355289421157684,0.6190195961255945,1.0,4/13,12.52%,ARHGAP6;WAS;BLNK;SRC
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.39243748198953815,-1.269789456891449,0.11467889908256881,0.6011407615635115,1.0,8/49,3.96%,ANXA3;PLA2G4A;CPNE8;ANXA4;ESYT2;ANXA5;ANXA2;ANXA1
prerank,cholesterol binding (GO:0015485),-0.40055894193931285,-1.2680912167202902,0.1348314606741573,0.6000274199761055,1.0,15/47,14.81%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL1A;PTCH1;STARD3;STARD4;OSBP2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.5340673749531768,-1.2631906589395194,0.1981651376146789,0.6087547035739087,1.0,6/13,19.48%,SLC7A2;SLC7A7;SLC38A5;SLC66A1;SLC7A1;SLC25A29
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.41652810998027495,1.2624500620145038,0.15114503816793892,0.6306463242206874,1.0,20/100,14.05%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;SNX20;OGT;RPH3A;TTPAL;MYO10;GAP43;PLEKHA5;HIP1;PLA2G4E;PIRT;ARHGAP9;ZFYVE28;ANKFY1;RLBP1;ATG2B
prerank,ADP binding (GO:0043531),-0.44842323693094044,-1.2618432100709271,0.1859504132231405,0.6064494476833385,1.0,7/25,11.51%,PRKAG2;MYO18A;ME1;MYH10;GCLC;MYO9B;ERN1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5660156861860778,-1.2597120791595142,0.22822299651567945,0.6062761962906843,1.0,5/11,16.68%,ATP10A;ABCA3;ABCA4;ATP8A1;ATP11A
prerank,ATP binding (GO:0005524),0.3578751063006773,1.2581665882483772,0.10539845758354756,0.634534716516023,1.0,45/266,12.09%,MYO1B;KCNJ8;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;SYN1;SIK1;MCM6;LIG4;PAPOLA;HSPA14;PEX1;STK3;MARK2;MAP4K4;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;BRSK1;LATS2;SRR;NLK;PFKM
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.2803660865012621,-1.2574723267379193,0.007751937984496124,0.6064845545459668,1.0,119/597,15.54%,NFIB;BNC2;PBX1;PKNOX2;MAF;SMAD3;FLI1;SMARCA2;SMAD6;NFAT5;FOXP1;HDAC4;GLI2;CUX1;TBL1XR1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;TCF7L2;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;CREB3L2;ZNF23;ARNT2;AR;BRD7;RARG;CREM;YAP1;GLIS2;SOX13;BHLHE40;CENPC;IRF1;TEAD1;SIX1;HLF;KDM5B;PRDM16;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT3;HINFP;NR2C2;KLF10;TBX1;TFCP2;IRF9;ZBTB18;VSX1;LHX6;FOXK1;CARM1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;PRDM5;TGIF1;ESRRG;KLF12;GATA2;CEBPG;NFYC;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;RELA;USF1;GATA6;CLOCK;ZW10;MEIS2;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;CREB3L1;HOXC4;HOXB5;HOXB7;SOX7;BEND3;SNAI1;CREB3;JUND;SREBF1
prerank,neuropeptide receptor activity (GO:0008188),0.5044484533341198,1.2566356336926074,0.218568665377176,0.6318714475122588,1.0,10/29,18.50%,TACR2;SORCS1;TACR1;NPSR1;GPR37;NPY1R;NTSR1;TACR3;NPY2R;SSTR2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5581898800468723,-1.2529111401794424,0.22082585278276481,0.6140775660873851,1.0,4/11,17.55%,SASH1;DAB2IP;PPEF2;ROR2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5922197756765576,1.2520567921910255,0.24678111587982832,0.6363625442680929,1.0,3/10,9.84%,NCF2;NCF1;NOX3
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.3255855164497808,-1.2492328748400041,0.07871720116618076,0.6183640687327401,1.0,29/134,11.61%,ABCC4;SLC6A13;SLC13A3;SLC1A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLCO2A1;SLC26A2;GJA1;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SFXN2;SLC16A11;SLC6A9;SLC7A5;SLC25A17;SLC6A1;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC25A24;SLC3A2;SLC38A6
prerank,steroid hydroxylase activity (GO:0008395),0.5505598712056147,1.2481198088341035,0.242914979757085,0.6395064604098938,1.0,1/16,0.61%,CYP7B1
prerank,lipase activator activity (GO:0060229),0.6073147039521396,1.245154340158651,0.2817796610169492,0.6405210665004392,1.0,1/10,1.07%,ARHGAP6
prerank,transcription coactivator binding (GO:0001223),-0.47305945462196214,-1.2444508082409984,0.2112676056338028,0.6264332738889108,1.0,10/20,15.49%,SMAD3;VGLL4;ESR1;THRB;AR;PGR;AHR;RELA;CDK9;RPL23
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5658986245806187,-1.2443268722399008,0.20670391061452514,0.6206342616825804,1.0,3/10,10.02%,MECOM;PRDM16;EHMT1
prerank,active ion transmembrane transporter activity (GO:0022853),0.4779488639477455,1.241318867668827,0.2158273381294964,0.6433165015087775,1.0,6/37,5.04%,SLCO3A1;COX4I2;NDUFA4L2;SLCO5A1;UQCRFS1;SLC22A8
prerank,exoribonuclease activity (GO:0004532),-0.5243937997291277,-1.2397686966027464,0.21389396709323583,0.6278155786663966,1.0,4/12,23.73%,CNOT7;ZC3H12A;EXOSC5;EXOSC7
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5598383118150587,1.2389466509264706,0.24842105263157896,0.6430769373610202,1.0,3/12,7.15%,PIK3CD;PIK3CA;PIK3C2A
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5612083475303109,1.2387609623631726,0.2634989200863931,0.638102971673468,1.0,4/12,10.60%,PIK3R1;SH2B3;IRS1;BLNK
prerank,chemokine receptor activity (GO:0004950),0.5055396427221046,1.2379865935502092,0.23856858846918488,0.6345544599653063,1.0,5/24,8.21%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,phospholipase activity (GO:0004620),0.42797698401945855,1.237190398435008,0.2084063047285464,0.631088097679567,1.0,7/67,7.18%,PLCL1;PLCE1;PLD6;LIPH;LIPC;ABHD3;PLAAT1
prerank,DNA binding (GO:0003677),-0.27119861476895063,-1.2360031168871664,0.00980392156862745,0.632558359100243,1.0,198/694,24.60%,NFIB;TSHZ2;FOXP2;PBX1;ZNF423;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;HDAC4;DENND4A;GLI2;CUX1;FOXO1;FOXO3;APP;ZIC2;ERG;NUPR1;RARB;MEOX2;FOXD1;DNMT3A;PLAGL1;TCF4;TCF7L2;FOXC2;LEF1;KLF2;TAF1;THRB;HOXA5;DDX60;HDGFL3;SSBP2;QRICH1;RARG;CREM;SOX13;THRAP3;CENPC;PDS5B;IRF1;TEAD1;SIX1;INO80;ZNF292;HLF;KDM5B;PRDM16;FOXC1;IRF2;SSBP1;CHD3;STAT1;BPTF;STAT3;HINFP;NR2C2;PGR;RAD51B;ZNF219;TBX1;RTF1;POLR2A;RC3H2;ERCC5;TFCP2;ZBTB18;DCLRE1C;AIFM1;FOXL1;REXO4;HIF1A;PCBP2;TRIM16;NHEJ1;NR4A2;ATF6;SAMHD1;IKZF1;ZC3H12A;PRDM5;ZKSCAN3;KLF12;BRCA2;NABP1;CEBPG;PATZ1;NFYC;DNASE1L1;AHR;LRRFIP1;ZIC3;RELA;PPARA;CHD2;MEF2A;USF1;CALR;ZGPAT;RPS27;TDG;CLOCK;XRCC4;SPHK1;MEIS2;EZH1;RFX2;RPL7;DDB1;RPA1;SLTM;POU2F1;ZBTB4;RAD50;CDK9;RPS15;TAF4B;SREBF1;APLP2;XRN1;CEBPZ;HHEX;MEIS1;GTF3C2;HMGB2;SPO11;GTF3C5;CENPB;USF2;JUNB;MYRF;TSHZ1;PSIP1;HMGN1;NFYB;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;DEDD;CEBPB;PARK7;SIRT3;YAF2;MCMDC2;RFC3;PPARGC1A;E2F1;SMARCAD1;GTF3C1;CTCF;POU2F2;POLRMT;SMC1A;HP1BP3;NFATC2;RAD52;THAP1;TOP3A;CHRAC1;GLI1;FOXD2;NR5A2;DEDD2;RFC1;SP7;XBP1;DNMT1;ZMYND11;TOP2A;RAD51C;NEIL3;ZNF513;NR4A3;MCM8;LYAR;HDGFL2;SMARCA4;WBP11;RAD51;CDC45;ERCC1;CBFB;ERCC2;MSH6;SATB1;BRCA1;PAX3;RNF11;FOXL2;EGR1;RPA3;POLR2G
prerank,CARD domain binding (GO:0050700),-0.5117819781450443,-1.231463880195328,0.2335907335907336,0.640154736334546,1.0,6/14,10.93%,NOD1;CASP4;CARD14;IRGM;CARD10;MAVS
prerank,actin binding (GO:0003779),0.3698072184482336,1.2247044990009952,0.15275813295615276,0.653141784644674,1.0,30/170,8.41%,EPS8;CALD1;CAP2;UTRN;DMD;SYNE1;PTK2;VCL;MYH9;FERMT2;SPEF1;SSH2;CORO7;NCALD;ADCY8;TMOD1;CORO2B;FMN2;EPS8L1;ACTN4;SPTB;ITGB1;RUSC1;SNCA;PDLIM1;SMTN;CAP1;MYL3;MYO6;CORO1A
prerank,pentosyltransferase activity (GO:0016763),0.47601930608455606,1.2243184268383718,0.2260536398467433,0.648594460143451,1.0,2/36,0.90%,ART3;PARP8
prerank,transmitter-gated ion channel activity (GO:0022824),0.4889249011540968,1.2240964863526358,0.2387218045112782,0.6438453450667515,1.0,12/29,18.54%,GRIK1;GABRG2;GRID1;GRIA2;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2;GABRB3;GRIA4;GRID2
prerank,phosphatidylinositol binding (GO:0035091),0.4072567112807549,1.223302909912999,0.21129032258064517,0.6403018570254724,1.0,12/91,6.72%,PITPNC1;PIGU;SCARB1;ITPR2;NCF1;EPB41;MREG;ITPR1;PITPNM2;RPH3A;WDFY3;APPL1
prerank,cadherin binding (GO:0045296),0.3473527316521904,1.2220325774508412,0.13164556962025317,0.638025546382161,1.0,34/315,7.13%,NOTCH3;TRPC4;MYO1B;CALD1;COBLL1;CDH2;CDH4;CEMIP2;VCL;PHLDB2;MPRIP;ARHGAP1;VASP;TNKS1BP1;MYH9;CD46;EFHD2;CDC42EP1;SPTBN1;CTNNA3;EPS8L1;TMOD3;ITGB1;CDH8;ANK3;CHMP2B;DDX3X;PDLIM1;CDH22;YWHAZ;CDH20;CDH19;CDH7;WASF2
prerank,fibroblast growth factor binding (GO:0017134),-0.4502410608338357,-1.2217104956364826,0.21115537848605578,0.6633470737059058,1.0,7/21,15.24%,FGFR2;THBS1;KL;RPS19;ITGB3;FGFR4;GLG1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3349670246775685,1.2213506004445036,0.10426540284360189,0.6346359211261288,1.0,59/431,10.73%,MYO1B;RASL12;REM1;KCNJ8;RERG;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;RND3;AGAP2;RRAD;AKT3;RPS6KA4;NOA1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;RAC3;MINK1;CLP1;RIT2;TUBA8;SYN2;ARL4C;RRM1;SYN1;SIK1;MCM6;LIG4;RAP1A;HRAS;PAPOLA;HSPA14;TUBB2B;RAB28;PEX1;STK3;RAB38;MARK2;MAP4K4;RNF112;GCK;MAP4K1;NEK6;ABCF3;DARS2;DYRK3;TUBG2;ARL5C;BRSK1
prerank,aminopeptidase activity (GO:0004177),0.4942599798884413,1.219689561656815,0.23639774859287055,0.6332094374828814,1.0,4/26,3.20%,ENPEP;METAP2;MMP15;ANPEP
prerank,sodium:proton antiporter activity (GO:0015385),-0.5321628956910571,-1.2190027257194302,0.2577696526508227,0.6652602570021765,1.0,3/11,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4176607412016203,1.2185721815797035,0.2127659574468085,0.6306076067085794,1.0,4/72,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.4338388905402463,-1.2170030866766308,0.22134387351778656,0.6650404009409839,1.0,6/27,11.28%,SLC9A2;SLC41A1;SLC8A3;SLC9B2;SLC9A9;SLC3A2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5138914213720543,1.2127627013152953,0.25851703406813625,0.6376757474243095,1.0,4/22,3.59%,RBMS3;CPEB1;RBM24;ELAVL4
prerank,metalloaminopeptidase activity (GO:0070006),0.5363663876359908,1.2113873125465175,0.2661290322580645,0.6354701943000036,1.0,3/16,3.20%,ENPEP;MMP15;ANPEP
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5476630592153332,-1.2111134503227892,0.24955436720142601,0.6755369041553242,1.0,6/10,28.90%,IDE;PML;DNAJB2;ANKRD13D;ANKRD13A;LAPTM5
prerank,ligand-gated cation channel activity (GO:0099094),0.41455757181783964,1.2096053950597847,0.2134453781512605,0.6342888208294947,1.0,18/75,16.32%,KCNJ8;KCNJ12;CHRNA3;GRIK1;ASIC2;GRIA2;CHRNA7;KCNJ3;GRIN2B;KCNJ6;ASIC3;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA1;P2RX5;GRIA4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.3036463188318722,-1.2092265466640701,0.08070175438596491,0.6746501994476833,1.0,49/188,18.15%,BNC2;PBX1;SMAD3;FLI1;SMARCA2;SMAD6;HDAC4;TBL1XR1;FOXO3;KLF4;TCF7L2;FOXC2;CREB3L2;AR;BRD7;YAP1;GLIS2;SOX13;IRF1;SIX1;PRDM16;FOXC1;CHD3;STAT3;HINFP;VSX1;FOXK1;CARM1;ATF6;PRDM5;NFYC;AHR;RELA;GATA6;HDAC5;ZNF568;TAL1;SOX17;CREB3L1;SOX7;JUND;HHEX;HMGB2;SOX18;NFYB;SOX12;CEBPB;KLF15;BASP1
prerank,BMP binding (GO:0036122),-0.5265351027578973,-1.2050445796740321,0.26062846580406657,0.680941757959248,1.0,3/11,6.39%,BMPR2;GREM2;NBL1
prerank,GDP binding (GO:0019003),0.4256522580241269,1.2000010775813814,0.24352331606217617,0.6487798378444056,1.0,8/63,7.86%,RASL12;RERG;RAB8B;RIT2;RAB3B;RAP1A;HRAS;RAB28
prerank,5'-nucleotidase activity (GO:0008253),-0.504042746020529,-1.1997754441676525,0.2335216572504708,0.6909395136544954,1.0,9/13,40.10%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,ubiquitin-specific protease binding (GO:1990381),0.5267347623995468,1.199214289152916,0.259958071278826,0.6454375206956181,1.0,3/19,6.51%,PTEN;DERL3;SART3
prerank,lipase activity (GO:0016298),0.44194228831590127,1.1973700041340882,0.24368231046931407,0.6444893636446636,1.0,5/43,7.16%,CEL;PLA1A;LIPH;LIPC;ABHD3
prerank,chloride channel regulator activity (GO:0017081),-0.4927271694381211,-1.1966857635837942,0.28330206378986866,0.6943805717047685,1.0,4/14,10.33%,WNK4;STX7;WNK1;STX1A
prerank,histone deacetylase activity (GO:0004407),-0.45663610668858096,-1.1944673998740407,0.26104417670682734,0.6953561796482615,1.0,8/19,18.46%,HDAC4;HDAC8;HDAC9;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3
prerank,histone acetyltransferase activity (GO:0004402),-0.41440606592385115,-1.1929380151993338,0.22708333333333333,0.6934427738570114,1.0,15/30,25.98%,KAT6B;KAT2B;TAF1;KAT14;ARRB1;BAZ1A;TADA2A;BRCA2;CLOCK;NAA40;USP22;MCM3AP;HAT1;ATF2;EPC1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5074779440139346,-1.1912473648206328,0.2672727272727273,0.6923563130217647,1.0,5/12,8.57%,IGF1;SOCS2;IGF2;ARRB1;GNAS
prerank,thioesterase binding (GO:0031996),0.5750093060739688,1.1908902194261752,0.3020833333333333,0.6531086567741311,1.0,8/11,26.97%,TRAF5;TRAF3;TRAF6;TRAF2;ARF6;TRAF1;HAUS7;CDC42
prerank,calcium ion binding (GO:0005509),0.3395513323046206,1.1896759871844569,0.16237113402061856,0.6508040392893059,1.0,60/323,11.72%,ASPN;CASQ2;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;RASGRP2;CEMIP2;SLIT1;SLIT3;ITPR2;RASGRP3;CIB3;EFHD2;NRXN1;PVALB;STIM2;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;RYR2;ATP2A2;CDH22;CDH20;CDH19;CDH7;AOAH;PADI2;STIM1;SYT1;RYR3;LETM1;PKD2;BNIP2;HPCA;CDH10;CDH18;SPOCK1;BAIAP3;ASAH2;PLA2G4E;KCNIP1;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR
prerank,double-stranded DNA binding (GO:0003690),-0.26720425878518667,-1.1881190943598692,0.015625,0.6954504685250313,1.0,99/531,15.54%,NFIB;PBX1;PKNOX2;MAF;FLI1;EGFR;NFAT5;FOXP1;GLI2;CUX1;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MAFG;ELF4;MEOX2;PRRX2;TBX15;KLF4;NR3C2;TCF4;FOXC2;NFATC1;LEF1;KLF2;THRB;HOXA5;ZNF23;DDX60;HDGFL3;ARNT2;RARG;CREM;GLIS2;BHLHE40;TEAD1;SIX1;HLF;KDM5B;IRF2;GLIS1;HIVEP1;STAT1;NR2C2;RAD51B;KLF10;TBX1;ERCC5;TFCP2;IRF9;ZBTB18;VSX1;LHX6;REXO4;FOXK1;NR4A2;ATF6;BHLHE41;HOXB9;TFCP2L1;TGIF1;ESRRG;KLF12;GATA2;CEBPG;BACH2;GLI3;FOXQ1;ELK3;AHR;ZIC3;MBNL2;USF1;GATA6;TDG;CLOCK;MEIS2;RFX2;HSF2;CREB3L1;HOXC4;RAD50;HOXB5;HOXB7;SOX7;SNAI1;CREB3;JUND;SREBF1
prerank,kinesin binding (GO:0019894),0.4858960457170307,1.1877562430510735,0.2830578512396694,0.6498513411056729,1.0,6/27,9.93%,CLSTN1;TOR1B;AP1G1;AP1AR;SNCA;NEK6
prerank,peptide hormone receptor binding (GO:0051428),0.5583218196124724,1.1869663021043022,0.2793522267206478,0.6467715359347691,1.0,2/11,7.59%,UCN2;CCK
prerank,protein kinase C activity (GO:0004697),-0.48685500288914546,-1.1857778935822627,0.24954128440366974,0.6961506857151772,1.0,6/14,10.98%,PRKCH;PRKCE;PRKCZ;PRKCB;PRKCD;PRKCG
prerank,Wnt-activated receptor activity (GO:0042813),0.5198128368985414,1.1852179661089783,0.28104575163398693,0.6460101733380287,1.0,4/15,4.94%,ROR1;FZD6;RYK;TSPAN12
prerank,NAD+ binding (GO:0070403),-0.4981976104967412,-1.1835714228153298,0.2673076923076923,0.6966523215607201,1.0,4/12,18.46%,CRYL1;PARP9;SIRT2;SIRT3
prerank,serine-type endopeptidase activity (GO:0004252),0.4008053993340752,1.1830878334413482,0.24792013311148087,0.6458241888455704,1.0,4/80,3.05%,TMPRSS4;FAP;RHBDD3;RHBDF1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.4081018509023462,1.1824471867319213,0.2191780821917808,0.6425107919497264,1.0,6/71,2.78%,PTPRK;PTEN;PALD1;PTPN9;TNS2;PTPN22
prerank,NADP binding (GO:0050661),-0.4006413796269731,-1.1815797443849536,0.22707423580786026,0.6963869285056766,1.0,13/32,27.28%,GMDS;LBR;NOS3;DPYD;ME1;NNT;PGD;NOS1;NOX1;DECR1;ME3;GRHPR;MTRR
prerank,myosin binding (GO:0017022),0.4195677319155896,1.1814275601153672,0.23201438848920863,0.6402179305219569,1.0,12/55,12.65%,CALD1;DMD;RAB39B;RAB3B;ARFGEF1;KIRREL1;CORO1A;NKD2;TRAK1;STXBP5L;TRAK2;NPHS1
prerank,monocarboxylic acid binding (GO:0033293),-0.46763393350037785,-1.1813529742214977,0.25971370143149286,0.6913140724097794,1.0,5/18,26.97%,CYP26B1;PSAP;RARA;RXRA;PYGL
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.381084050060347,-1.1808138418794862,0.2208067940552017,0.6872528282335425,1.0,10/42,7.44%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BSG;BAIAP2;ANXA1;PALLD;CNN3;CD47
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5156817059492834,-1.1806527503116597,0.25226860254083483,0.6820957348880025,1.0,3/11,10.55%,KCNK2;KCNQ1;KCNT1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.4044365383896665,-1.1802875410615188,0.24532224532224534,0.6776535697670966,1.0,16/29,33.63%,ACER2;ACER3;CTBS;PGGHG;ADPRS;GANAB;GAA;NEU3;HEXD;MOGS;ENGASE;GLA;HPSE;HYAL3;GALC;LCT
prerank,MAP kinase phosphatase activity (GO:0033549),-0.4993439173862295,-1.1742723766530636,0.2843691148775895,0.6889583307763117,1.0,6/12,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,phospholipid transfer activity (GO:0120014),0.4925695029546488,1.1741439147190387,0.3092105263157895,0.6506716957302413,1.0,3/21,6.57%,PITPNC1;PITPNM2;PRELID3A
prerank,syntaxin binding (GO:0019905),-0.3490519716228839,-1.1721649822910207,0.17889908256880735,0.689657212992592,1.0,19/61,21.44%,DAPK1;UNC13B;ABCA1;RAB11A;LRRK2;STX7;SNAP23;STXBP4;STX6;SCFD2;SNAP47;NAPA;BLOC1S6;SYT9;VPS52;PTPN2;TMED9;UNC13C;VAMP8
prerank,manganese ion binding (GO:0030145),-0.37382435426903254,-1.1703311169264148,0.20905172413793102,0.6893531661564705,1.0,21/48,30.13%,LARGE1;B4GALT1;XPNPEP1;MPPED2;PPM1M;ME1;MGAT1;MTPAP;MGAT2;ADCY2;FAM20C;NUDT16;MPPE1;HMGCL;XXYLT1;SOD2;ABL1;ATP13A2;ENDOU;POMGNT1;WRN
prerank,pyrophosphatase activity (GO:0016462),-0.36981580408745607,-1.1690116053294373,0.23385300668151449,0.6875238522169377,1.0,27/50,33.34%,ENTPD1;ENPP1;ENPP3;NUDT4;ALPL;NUDT3;PLPP1;ENTPD5;LHPP;ENTPD2;DOLPP1;NUDT6;PLPP4;CILP;PPA1;NUDT16;NUDT1;CILP2;TRPM2;BNIPL;DXO;ENTPD3;NUDT5;NUDT10;NUDT9;DHX29;FITM2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.44239299127032145,1.1684083351212553,0.25760286225402507,0.6579094626885407,1.0,2/47,1.78%,SLC38A11;SLC1A5
prerank,ATPase binding (GO:0051117),-0.3388508464115728,-1.1667039655182287,0.20185614849187936,0.6886032953466965,1.0,19/71,11.80%,ABCA1;EGFR;ATP1B3;TMTC4;SNTA1;PTPN3;CAV1;SLC2A13;ESR1;EZR;ATP6V0A4;AR;PGR;ATP6V1G1;TOR1AIP1;CHMP4A;NOP58;ATP6V0A1;TCIRG1
prerank,transcription cis-regulatory region binding (GO:0000976),-0.26855926953211984,-1.1662357100109009,0.05,0.6846255340241225,1.0,91/406,18.15%,BNC2;PBX1;FOXN3;AEBP1;SMAD3;FLI1;SMARCA2;SMAD6;FOXP1;HDAC4;CUX1;TBL1XR1;OSR1;FOXO3;NR3C1;MLXIP;KLF4;PLAGL1;TCF7L2;FOXC2;TFDP2;LEF1;ETV6;MXI1;CREB3L2;AR;BRD7;CREM;YAP1;HIF3A;GLIS2;SOX13;IRF1;TEAD1;SIX1;PRDM16;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;KLF10;ZBTB8A;TFCP2;VSX1;LHX6;RREB1;HIF1A;TWIST2;FOXK1;CARM1;ATF6;FOSL2;PRDM5;NFYC;GLI3;ELK3;AHR;HDAC1;RELA;MEF2A;GATA6;HDAC5;ZNF568;TAL1;SOX17;HSF2;CREB3L1;ENO1;ZBTB4;SOX7;SNAI1;CREB3;JUND;SREBF1;HHEX;HMGB2;SOX18;MNT;ZFP69;ZNF436;ATF1;NFIL3;NFYB;NFXL1;SOX12;CEBPB;KLF15;PARK7;BASP1
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.3458193674932931,-1.1635875795420085,0.19946091644204852,0.6865672043829302,1.0,11/70,11.40%,GXYLT2;EXT1;LARGE1;B4GALT1;CSGALNACT1;CHSY1;HEXA;HEXB;B3GALNT1;POGLUT1;POGLUT2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4170835665692209,1.163264381338873,0.2512820512820513,0.6644509104279931,1.0,6/60,4.23%,PTEN;CTDSPL;PHLPP1;PPM1E;PPP3CA;LRRC40
prerank,symporter activity (GO:0015293),-0.5250036186924296,-1.162553114324831,0.28807339449541286,0.6841086920137242,1.0,3/10,13.15%,SLC5A6;SLC5A5;MFSD2A
prerank,cation:chloride symporter activity (GO:0015377),0.551240540274994,1.1599623146368154,0.31777777777777777,0.6665904225289131,1.0,4/10,13.22%,SLC12A2;SLC12A6;SLC12A5;SLC12A4
prerank,GABA-A receptor activity (GO:0004890),0.5095204894971895,1.1592800362456341,0.3019271948608137,0.663475945131656,1.0,6/18,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABRB2
prerank,disordered domain specific binding (GO:0097718),-0.42276293988646935,-1.1592765415336765,0.25595238095238093,0.6881502236720983,1.0,9/23,21.23%,FN1;CALM2;MDM2;HSP90AB1;CALM1;PPIL1;NUMA1;TEAD2;DFFB
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.39915892931173336,-1.1544410031660806,0.25206611570247933,0.690807677883468,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.39915892931173336,-1.1544410031660806,0.25206611570247933,0.690807677883468,1.0,16/34,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,WW domain binding (GO:0050699),0.47125031455055477,1.1541628923393887,0.29454545454545455,0.66965751775279,1.0,2/26,3.17%,RAPGEF2;NDFIP2
prerank,cysteine-type peptidase activity (GO:0008234),-0.33875846834964296,-1.1517469634342619,0.2127659574468085,0.6932941356966228,1.0,21/73,15.97%,CTSH;USP47;CAPN2;CTSC;USP46;CASP4;USP12;USP8;USP15;USP18;CTSB;USP34;CASP8;USP35;USP11;USP5;CTSS;USP49;SFRP1;PDIA3;CASP6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5258541150591851,-1.1484090810329535,0.2938856015779093,0.6973283417285765,1.0,1/10,0.92%,KDM7A
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.4758679467283338,-1.1464981375199896,0.2879684418145957,0.6976066277999385,1.0,4/14,6.05%,TIMP3;RECK;TIMP2;SPOCK2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.38327879812810106,1.146132208390063,0.277337559429477,0.6815817766821876,1.0,4/91,2.26%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,tubulin binding (GO:0015631),0.32844534085503874,1.1441028555749089,0.2181122448979592,0.6812980567784205,1.0,42/296,11.88%,DLEC1;SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;NCALD;SVBP;FGF13;IFT81;NAV3;GAS8;CLASP2;MAPRE2;ARL4C;SNCA;DDX3X;TPPP;APPL1;KIF26B;HOOK3;TTLL11;FAM161A;MAP4K4;CLIP2;TTLL12;NUSAP1;KIF3A;UXT;BRSK1;ARHGEF7;TOGARAM2;MACO1;TPGS1;CCDC66;PAK1;KIF20A;KIF5C;APC;KIF3C
prerank,endopeptidase activity (GO:0004175),-0.27666989854802704,-1.1435612936932689,0.13963963963963963,0.7006759366977114,1.0,57/257,16.08%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;ADAMTS2;THSD4;CTSH;PCSK5;ADAMTS9;F3;HTRA3;ADAMTS5;DPP4;USP47;ADAM9;CTSC;USP46;ADAM10;CASP4;ACE;ADAMTS1;USP12;ADAMTS15;ADAMTSL1;USP8;KLK2;USP15;ADAMTSL4;PIK3IP1;USP18;MMP14;CTSB;USP34;CASP8;IDE;MMP19;USP35;USP11;USP5;ADAMTS14;RHBDF2;CTSS;ADAMTS3;USP49;PSMB4;PREP;SPG7;RHBDL3;SFRP1;PSMB1;ADAM33;MMP2;PDIA3;CASP6;AFG3L2;ADAMTSL5
prerank,receptor ligand activity (GO:0048018),-0.2807107372741602,-1.1433705564807366,0.12992125984251968,0.6961550431771357,1.0,29/245,7.70%,BMP6;IGF1;EPHA7;WNT4;SEMA3D;BMP7;SEMA6A;TGFA;SEMA3C;IL15;WNT6;DPP4;BMP4;SEMA7A;CSF1;WNT9A;VEGFD;TNFRSF11B;VEGFC;IL16;IGF2;GAS6;FGF1;GREM2;WNT5A;CCL15;NBL1;SEMA3E;OSGIN2
prerank,guanyl ribonucleotide binding (GO:0032561),0.34212851240188497,1.1423255374155226,0.24027777777777778,0.6809681918436189,1.0,22/196,8.86%,RASL12;REM1;RERG;RAPGEF2;PDE5A;RND3;AGAP2;RRAD;RAB8B;SLC19A1;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAB3B;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5449667701821351,1.1417069673231843,0.3169642857142857,0.6777438359622129,1.0,3/11,14.69%,CHRNA3;CHRNA7;CHRNB2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5145054776833706,1.1410566852564916,0.3219954648526077,0.6747336612989859,1.0,3/17,5.14%,PITPNC1;PITPNM2;ATP8B2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.38663844391110214,-1.1388343328499007,0.27155172413793105,0.703718344616871,1.0,17/32,36.18%,KDM7A;TET3;EGLN2;TMLHE;EGLN3;FTO;TYW5;PHYHD1;ALKBH5;TET2;EGLN1;JMJD7;TET1;HIF1AN;RIOX1;PHYH;KDM4A
prerank,general transcription initiation factor binding (GO:0140296),-0.4081172583161655,-1.1387698334641077,0.28958333333333336,0.6989862309790008,1.0,11/25,26.26%,ESR1;TAF1;AR;AHR;RELA;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,MAP kinase kinase activity (GO:0004708),-0.458733881711705,-1.1371016000074348,0.296078431372549,0.6987249939382496,1.0,5/15,14.99%,LRRK2;MAP2K6;MAPK14;MAP2K5;MAPKAPK3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.5206974988272692,-1.1361833402342005,0.32196969696969696,0.6914163430711769,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.5206974988272692,-1.1361833402342005,0.32196969696969696,0.6914163430711769,1.0,6/10,29.87%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,ionotropic glutamate receptor activity (GO:0004970),0.49989742316790664,1.136048665767361,0.3188405797101449,0.6806033168111255,1.0,8/17,16.32%,GRIK1;GRIA2;GRIN2B;GRIK5;GRIK2;GRIN2A;GRIA1;GRIA4
prerank,potassium ion antiporter activity (GO:0022821),-0.45574691941121803,-1.1339277005733102,0.3147482014388489,0.6926044630885179,1.0,3/15,6.96%,SLC24A3;SLC9A2;SLC9A9
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.42897471778480434,-1.1325934431383433,0.30612244897959184,0.6916880099692531,1.0,4/20,7.96%,TJP2;DLG1;MAGI3;CMPK1
prerank,transition metal ion binding (GO:0046914),-0.2604276461712072,-1.1318955007863203,0.1,0.6887597132265743,1.0,107/397,20.85%,SMAD3;LARGE1;KDM7A;B4GALT1;HDAC4;GLI2;MOXD1;AOX1;PAM;AGMO;PAPPA;EEA1;ENPP1;XPNPEP1;MYRIP;SHANK3;NPEPPS;MPPED2;SEC23A;SEC24D;NOS3;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;ATOX1;LACC1;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;PPM1M;CHD3;RNPEP;ME1;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;MGAT1;DPP3;ZMYND8;FTL;IDE;SAMHD1;MTPAP;KDM3A;DNAJC24;NSD1;GCH1;MGAT2;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;ISCA2;TYW5;SMPDL3A;PLSCR3;NOS1;TIMM13;TRIM8;SIRT2;FBXL19;PARK7;FTH1;SIRT3;ZCCHC4;ADCY2;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;FNTB;FAM20C;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,sterol binding (GO:0032934),-0.3469044705806306,-1.1313443641176815,0.26520681265206814,0.6855652184657458,1.0,17/56,14.81%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL9;OSBPL1A;INSIG2;PTCH1;STARD3;STARD4;OSBP2
prerank,transcription coregulator binding (GO:0001221),-0.35510723911960446,-1.1312241708096076,0.26576576576576577,0.6812417919607242,1.0,19/50,20.84%,SMAD3;ZBTB16;LCOR;VGLL4;ESR1;THRB;AR;LMO2;PGR;EHMT1;USP11;AHR;RELA;CDK9;RPL23;EZH2;CIT;CTCF;TEAD2
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5431125551117353,1.1302541135011195,0.3391304347826087,0.6882444922009425,1.0,2/11,1.24%,MAP3K20;MAP3K5
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4824114230971911,1.129565225844361,0.32450331125827814,0.6852008087828655,1.0,7/20,13.00%,USP25;SENP5;OTUD5;DESI2;SENP1;OTUB1;USP50
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4588129014666882,-1.1291855119924696,0.30708661417322836,0.682016280945888,1.0,2/14,2.95%,SLC26A7;SLC26A2
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.47008509715856545,1.1285310052761388,0.32677165354330706,0.682843438073148,1.0,5/22,10.28%,ATP2A3;ATP2C1;ATP6V0E2;ATP2A2;ATP6V1B2
prerank,hexosyltransferase activity (GO:0016758),-0.31186190402294156,-1.1243289079176073,0.2430167597765363,0.6900306438849503,1.0,11/101,6.89%,TMTC1;EXT1;LARGE1;B4GALT1;TMTC4;CSGALNACT1;TMTC2;A4GALT;CHSY1;HEXA;HEXB
prerank,endopeptidase inhibitor activity (GO:0004866),0.37570404061986773,1.123129515801344,0.3017656500802568,0.6899389329019877,1.0,13/82,11.21%,SERPINI1;SERPINB8;COL4A3;ROCK1;WFDC3;SERPINA10;PSMF1;BIN1;BIRC6;SPOCK3;SERPINA2;SPOCK1;PTTG1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.46263503524186833,-1.1221565152397743,0.3314500941619586,0.6910143253373765,1.0,1/15,1.12%,PLA2G4A
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.3547126321856823,-1.1190818959993,0.27191011235955054,0.694817348959724,1.0,12/44,19.82%,MECOM;SMYD3;SETD7;SETD1B;KMT5A;PRDM16;EHMT1;NSD1;KMT5C;EZH2;SMYD5;SETDB1
prerank,metal ion binding (GO:0046872),0.3079439085658834,1.116842892028769,0.22461170848267623,0.6989654889071487,1.0,80/477,11.79%,ASPN;CASQ2;MAP3K20;ADGRL3;CDH2;CDH4;RAPGEF2;DYSF;AIF1L;MAP3K5;RASGRP2;SNRK;CEMIP2;SLIT1;SLIT3;MARK1;ITPR2;RASGRP3;NUAK2;CIB3;EFHD2;NRXN1;PVALB;STIM2;CDC42BPA;UBA2;STK38L;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;SLC25A13;RPH3A;CDH8;SNCA;TPPP;RYR2;ATP2A2;SIK1;CDH22;CDH20;CDH19;CDH7;AOAH;PADI2;PAPOLA;MTHFD2;STIM1;STK3;SYT1;RYR3;LETM1;MARK2;PKD2;BNIP2;HPCA;NEK6;CDH10;CDH18;DYRK3;ABL2;SPOCK1;BAIAP3;BRSK1;ASAH2;PLA2G4E;KCNIP1;RPE;PGS1;CASQ1;BRAF;CHP2;MICU3;SYT2;KCNIP4;SRR;NLK
prerank,protein kinase activator activity (GO:0030295),0.39469782998093195,1.1167423348670291,0.30016863406408095,0.694777130744406,1.0,13/60,8.70%,GPRC5C;AFAP1L2;RGCC;AGAP2;NRG1;GRM5;FGF13;SPDYA;SPRY2;DDX3X;CDKN1A;STK3;MARK2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.33985102859665905,1.1149750325780847,0.26895565092989987,0.6942089263553702,1.0,17/173,5.07%,TBX2;HEY2;HEYL;ZEB1;PRDM1;TRPS1;ZBTB34;TBX3;ZFHX3;NR2F1;ZEB2;HESX1;NKX6-3;SCRT2;PPARD;ZBTB45;SREBF2
prerank,proton transmembrane transporter activity (GO:0015078),0.4306961658540265,1.1144379252910173,0.32013769363166955,0.6909732437369037,1.0,6/39,11.86%,COX4I2;NDUFA4L2;UQCRFS1;ATP6V1B2;COX4I1;COX5A
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3737730064314899,1.1135944953265184,0.3117744610281924,0.688562906253549,1.0,11/85,10.75%,NDST3;CEL;PON2;LIPC;ABHD3;PLAAT1;AOAH;MRPL58;ACHE;GDPD1;PLA2G4E
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.44777981845735415,-1.112912794472662,0.361003861003861,0.7064528006809926,1.0,2/15,5.64%,PLA2G4A;SESTD1
prerank,protein phosphatase activator activity (GO:0072542),-0.456992522721555,-1.1119748867069976,0.3185483870967742,0.704340052399273,1.0,5/13,18.58%,IGFBP3;PTPA;CALM2;CALM1;PPP2R5C
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4511624976249637,1.1110469437398258,0.33574007220216606,0.6894613513939726,1.0,11/26,22.02%,PABIR1;PTN;PPP1R14A;PPP1R11;SET;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3693431716651656,-1.1104931263206665,0.31529411764705884,0.7035016211842561,1.0,12/38,20.78%,PLA2G4A;SESTD1;WIPI2;ZFYVE19;PARD3;DAB2IP;PLEKHA4;SNX21;ATG2A;ZFYVE1;SNX3;BBS5
prerank,platelet-derived growth factor binding (GO:0048407),-0.48349789609819943,-1.1084398965033273,0.3800383877159309,0.7043287138634589,1.0,6/11,2.39%,COL1A2;COL3A1;COL1A1;PDGFRA;COL5A1;COL6A1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.486081924837041,1.1075635188003632,0.33402489626556015,0.6924327383486287,1.0,3/15,8.21%,CCRL2;ACKR2;CCR9
prerank,endopeptidase regulator activity (GO:0061135),-0.3608779497056517,-1.1068414766523382,0.27896995708154504,0.7038471113375442,1.0,6/40,11.10%,RECK;CAST;ITIH2;SERPIND1;CST3;PSME2
prerank,omega peptidase activity (GO:0008242),0.3686523075760611,1.105425423782291,0.3198051948051948,0.6927978717995398,1.0,10/89,6.64%,GGT5;GGT1;USP25;JOSD2;GGH;USP40;OTUD5;UCHL1;DESI2;PAN2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4591798534775007,-1.1038497521258273,0.36764705882352944,0.7075927239950904,1.0,3/13,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,cation transmembrane transporter activity (GO:0008324),-0.348033425113047,-1.1019630979807007,0.30663615560640733,0.7081620128873887,1.0,26/48,33.35%,SLC6A6;SLC41A1;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC39A1;SLC66A1;SLC7A1;SLC22A2;SLC36A1;SLC1A1;SLC38A1;MFSD12;PKD1L3;SLC6A7;SLC36A2;SLC7A3;SLC22A3;SFXN3;MMGT1;OCA2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.49088724852242793,-1.1010340314811957,0.3428063943161634,0.7061692407350585,1.0,6/11,33.30%,NUDT4;NUDT3;NUDT16;NUDT1;NUDT5;NUDT10
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4674078645910472,-1.1001961677085028,0.34782608695652173,0.7038956772844243,1.0,3/12,6.96%,SLC9A2;SLC9B2;SLC9A9
prerank,pre-mRNA binding (GO:0036002),-0.38566900308747715,-1.0973081035816572,0.3292929292929293,0.707291440588539,1.0,2/28,3.83%,CELF2;DDX5
prerank,acetylcholine receptor activity (GO:0015464),0.458124706804127,1.0959477789409608,0.34980237154150196,0.7079098355310353,1.0,6/22,18.01%,CHRNA3;CHRNA7;CHRFAM7A;CHRNB2;CHRM3;CHRM2
prerank,mRNA 5'-UTR binding (GO:0048027),-0.39338973167835073,-1.0958240027162203,0.3426294820717131,0.7070531953471505,1.0,8/24,17.92%,RPS14;RPL41;RPS13;IGF2BP2;MYH10;RPL26;LARP1;RPS7
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.49217166971043946,1.090718722486607,0.36989247311827955,0.7145773468888317,1.0,3/14,9.84%,NCF2;NCF1;NOX3
prerank,nuclear receptor coactivator activity (GO:0030374),0.39991135219812946,1.0890448287291883,0.33907056798623064,0.7137744695248683,1.0,16/52,9.59%,PKN1;NCOA7;ETS1;NCOA3;PPARGC1B;FGF2;TACC1;ACTN4;ELK1;MED13;RBM14;NCOA6;SS18;CCAR2;MED1;CNOT9
prerank,sulfotransferase activity (GO:0008146),-0.3654766632353375,-1.0890296751853794,0.316,0.7204840534275796,1.0,7/33,11.97%,UST;CHST11;HS3ST3A1;HS6ST1;SULT1A1;CHST15;HS3ST1
prerank,rRNA binding (GO:0019843),-0.3530988344466419,-1.0883904673909897,0.31333333333333335,0.7178179082154806,1.0,18/42,25.15%,RPS14;CAVIN1;RPS13;RPS9;RPL12;RPL11;RPS5;MDM2;MRPS7;MRPS6;MRPS18A;RPL23;RPLP0;RCC1L;UTP23;FASTKD5;RRS1;RPS3
prerank,hyaluronic acid binding (GO:0005540),-0.4804349880132909,-1.0880998638225308,0.387037037037037,0.7143517402358305,1.0,4/10,25.35%,CEMIP;LAYN;LYVE1;CD44
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.410380186607671,-1.0864449103230693,0.3790322580645161,0.7141462604240237,1.0,5/20,20.51%,AGPAT4;LPGAT1;PLA2G15;AGPAT2;DGAT2
prerank,protein kinase regulator activity (GO:0019887),0.3611616799777074,1.0847034754383171,0.3282674772036474,0.7181793980980937,1.0,20/95,10.76%,GPRC5C;RGCC;SPRY4;PRKAR1B;AGAP2;FGF13;SPDYA;HEXIM1;CXCL10;PRKAR2B;SNCA;TAOK3;CDKN1A;PRKAR2A;ANKRD54;CCNC;MARK2;CCNYL1;PRKAR1A;PRKRIP1
prerank,nucleotidase activity (GO:0008252),-0.4368922710871047,-1.0835688663065446,0.3612167300380228,0.7169695684349222,1.0,9/15,40.10%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.4331584340132116,1.0833347563705444,0.34555984555984554,0.71671475798284,1.0,11/29,10.18%,PRKAR1B;SPRED1;PKIA;SPRY2;HEXIM1;PRKAR2B;CDKN1A;PRKAR2A;INCA1;INKA2;PRKAR1A
prerank,kinase activity (GO:0016301),0.3528640672116757,1.0817987014981196,0.33280757097791797,0.7154971240755957,1.0,19/109,10.63%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;STK39;ITPKB;NEK1;PIK3C2A;MTOR;MAP4K4;SEPHS2;LYN;GK;COQ8A;PRKD3;NMRK1;DGKD;COASY
prerank,anion transmembrane transporter activity (GO:0008509),-0.470250784364752,-1.081179744927142,0.3680297397769517,0.718973638453298,1.0,4/12,10.60%,SLCO2B1;ABCG2;SLC22A6;SLC39A8
prerank,DNA polymerase binding (GO:0070182),-0.4247611376768107,-1.0800193419411783,0.33595284872298625,0.7175508609432198,1.0,8/18,23.22%,SMG6;FANCI;CDK2AP1;HSP90AB1;NAT10;ACD;SMARCA4;RAD51
prerank,lysine-acetylated histone binding (GO:0070577),-0.4084179659312547,-1.078727033565297,0.3642105263157895,0.7125276422850251,1.0,6/20,9.76%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),-0.4084179659312547,-1.078727033565297,0.3642105263157895,0.7125276422850251,1.0,6/20,9.76%,TAF1;MLLT3;TRIM24;BRD7;ZMYND8;CARM1
prerank,nucleotidyltransferase activity (GO:0016779),-0.41797754495585393,-1.076784692973691,0.3667296786389414,0.7133437952044887,1.0,7/19,20.22%,REV1;PAPSS2;TUT4;TUT7;MTPAP;PNPT1;TENT4B
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.4903503179588895,1.0752660028901124,0.3673913043478261,0.7248378494948635,1.0,5/13,17.93%,GABRG2;GABRA2;GABRA5;GABRA4;GLRB
prerank,ligand-gated anion channel activity (GO:0099095),0.4714173096327196,1.0751843152058556,0.3866943866943867,0.7208637946550845,1.0,7/17,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GLRB;GABRB2
prerank,calcium:sodium antiporter activity (GO:0005432),-0.48157043778990904,-1.0740642075048707,0.3857404021937843,0.715810761806466,1.0,3/10,11.28%,SLC24A3;SLC8A3;SLC3A2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4796392914258989,1.0736390023592493,0.37014314928425357,0.7198910323448122,1.0,3/15,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,chemorepellent activity (GO:0045499),-0.38538976147927845,-1.071334911467414,0.36065573770491804,0.7185967412276824,1.0,6/25,3.63%,EPHA7;SEMA3D;SEMA6A;SEMA3C;DPP4;SEMA7A
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.43477701977740457,-1.068807122726649,0.3824130879345603,0.7206793805227357,1.0,3/15,10.60%,SLC26A7;SLC26A2;SLC39A8
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4591290744569946,1.0672598201888852,0.39801980198019804,0.7288505122812882,1.0,1/20,0.46%,SLC30A10
prerank,semaphorin receptor binding (GO:0030215),0.44347142253685773,1.0671616215041282,0.38537549407114624,0.7249262169207142,1.0,6/23,4.91%,SEMA6D;SEMA5A;PLXNB1;SH3BP1;SEMA6C;RIT2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4456491381706373,1.0663655601191422,0.3972602739726027,0.7223852346261603,1.0,7/21,10.00%,WASF3;AKAP1;AKAP6;ARFGEF1;RYR2;WASF2;AKAP7
prerank,myosin II binding (GO:0045159),-0.47861786706795156,-1.0648428900643874,0.39892665474060823,0.7267602736555923,1.0,4/10,14.91%,GSN;SHROOM4;TRIOBP;LLGL2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4960376129468328,1.063539163449332,0.40045766590389015,0.724126540673788,1.0,2/11,3.40%,SLC19A1;SLC25A25
prerank,DNA polymerase activity (GO:0034061),-0.3937763791953284,-1.0588336668023755,0.3903846153846154,0.7378666768947529,1.0,9/22,29.84%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,SUMO binding (GO:0032183),0.47789477405477176,1.0580436720063982,0.3969957081545064,0.7314561816863918,1.0,2/13,3.78%,USP25;UBA2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4262171955728568,1.057117447002869,0.39517625231910947,0.7292596639186614,1.0,8/30,15.66%,SLC30A10;ATP7A;TTYH1;ATP7B;SLC31A1;SLC30A5;SLC39A6;SLC25A37
prerank,protein phosphatase binding (GO:0019903),0.3368142091044634,1.057079636098188,0.36911764705882355,0.725336781748544,1.0,16/117,10.22%,ITGA1;SMTNL2;MAP3K5;PTK2;PIK3R1;AKAP11;ADCY8;MYO16;JAK1;ROS1;ANKLE2;TRAF3;PTPRT;PPP1R16A;STRN;KIF3A
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3972680968657673,-1.0568428028071584,0.40789473684210525,0.7387906672385354,1.0,9/21,29.84%,REV1;POLM;POLH;POLI;CHRAC1;POLE2;POLA1;POLD1;POLE3
prerank,kinase activator activity (GO:0019209),0.4243606331147622,1.0563088476259785,0.3877917414721723,0.7230737856215689,1.0,5/30,4.44%,GPRC5C;RGCC;AGAP2;FGF13;SPDYA
prerank,cardiolipin binding (GO:1901612),-0.4798179341533876,-1.0560055394696957,0.40831758034026466,0.7368369586841511,1.0,4/10,30.55%,GSDME;GSDMD;PLEKHN1;STOML2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4628931105870895,-1.0553767586441252,0.40074906367041196,0.7343608368251349,1.0,2/12,2.85%,AOX1;XDH
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4676505379335275,1.0537855207563465,0.4176954732510288,0.7243083938498893,1.0,3/16,5.46%,SLC1A5;SLC1A4;SLC25A13
prerank,TBP-class protein binding (GO:0017025),-0.3948312407386882,-1.0520320483512902,0.39789473684210525,0.7384646363915311,1.0,9/21,26.26%,ESR1;TAF1;AHR;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,neurexin family protein binding (GO:0042043),0.5072019592597233,1.0517726448926443,0.3821138211382114,0.7246686575779798,1.0,1/10,0.66%,CEL
prerank,ferrous iron binding (GO:0008198),-0.39653006123319273,-1.050617214088715,0.3786407766990291,0.7380721992320642,1.0,14/21,38.48%,EGLN2;EGLN3;FTL;DNAJC24;FTO;FTH1;TET2;EGLN1;CDO1;HIF1AN;ACP5;HAAO;PHYH;HEPH
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.26431687871704906,-1.0502601356209984,0.3333333333333333,0.7348781043066842,1.0,40/181,15.40%,SMAD3;HDAC4;MDFIC;ANXA4;KLF4;TACC2;TCF7L2;NFATC1;TAF1;ZFPM2;PARP9;ARNT2;WWP2;AR;PRRX1;RERE;GTF2I;BHLHE40;ATN1;MAPK14;LMO2;STAT1;STAT3;IFI27;FIZ1;DTX3L;BBS7;HIF1A;BHLHE41;HDAC1;RELA;PPARA;ID2;MEF2A;HDAC5;TAL1;ACTB;HIPK2;TAF4B;ZFPM1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.4419494333893833,-1.0468780709689853,0.42003853564547206,0.7393944863504274,1.0,7/12,38.24%,KDM7A;KDM3A;HR;KDM1A;JMJD1C;KDM4A;PHF2
prerank,calcium-release channel activity (GO:0015278),0.46693332748898386,1.0457756621091543,0.4206008583690987,0.7327079094878408,1.0,6/17,12.93%,ITPR2;ITPR1;RYR2;RYR3;PKD2;RASA3
prerank,estrogen receptor binding (GO:0030331),0.41101854777759,1.0451276888986727,0.391304347826087,0.7301564421289417,1.0,8/32,10.15%,RERG;PPARGC1B;TACC1;ARID5A;PADI2;NCOA6;MED1;STRN
prerank,DNA-binding transcription factor binding (GO:0140297),-0.26131149309003193,-1.04359330063785,0.3473684210526316,0.7437839893453807,1.0,41/189,13.78%,SMAD3;HDAC4;FHL2;HDAC7;KLF4;TCF7L2;TLE4;NFATC1;TAF1;HDAC9;SKI;ZFPM2;WWP2;AR;CREM;YAP1;PRRX1;RERE;GTF2I;BHLHE40;ATN1;PRDM16;LMO2;STAT1;STAT3;IFI27;FIZ1;BBS7;TLE2;ZMYND8;TLE1;BHLHE41;PRDM5;HDAC1;RELA;PPARA;ID2;MEF2A;USF1;HDAC5;TAL1
prerank,tau-protein kinase activity (GO:0050321),0.4398935885491449,1.0413807833501594,0.4161735700197239,0.7341755176156711,1.0,9/20,18.48%,MARK1;ROCK1;TTBK1;MARK2;BRSK1;PRKAA1;CDK5;GSK3B;MARK4
prerank,ephrin receptor binding (GO:0046875),0.441973328691729,1.039819455515963,0.42115768463073855,0.7335385546858106,1.0,5/21,13.16%,CHN1;ANKS1B;LYN;SRC;PTPN1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2964830791285092,1.0384671918011037,0.37966537966537967,0.7325460570940184,1.0,59/335,11.50%,MAST4;MAP3K20;KALRN;CDK6;MAP3K5;MYLK;SNRK;PKN1;MARK1;HUNK;NUAK2;ROCK1;AKT3;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;SRPK3;RPS6KB2;MINK1;CSNK1G1;RPS6KA2;TESK2;MYLK4;TESK1;TTBK1;TAOK3;SIK1;PAK6;PIKFYVE;RIPK2;STK24;STK3;MTOR;ALPK1;GRK5;ACVR2B;MARK2;MAP4K4;PRKD2;CSNK1E;MAP4K1;PAK5;PRKD3;PDIK1L;MAPK10;NEK6;ATR;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1
prerank,mechanosensitive ion channel activity (GO:0008381),-0.44845941239978515,-1.03633161789514,0.4230769230769231,0.7574864721382059,1.0,3/12,11.08%,PIEZO2;PIEZO1;TMC6
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.443619128393792,1.0352381658709469,0.4068441064638783,0.7353102175203141,1.0,4/18,10.26%,PIK3R1;AGAP2;SOCS5;SOCS6
prerank,protein kinase inhibitor activity (GO:0004860),0.38292590601125853,1.032677538827822,0.40754039497307004,0.7366806737596202,1.0,9/42,10.76%,SPRY4;SPRED1;SPRY2;HEXIM1;SNCA;TAOK3;CDKN1A;INKA2;PRKRIP1
prerank,sodium channel regulator activity (GO:0017080),0.39903733324324914,1.0288021069964892,0.41947565543071164,0.7407823587380382,1.0,9/37,11.62%,NEDD4L;FGF12;FXYD2;FGF13;PRSS8;SCN2B;RANGRF;FGF11;FGF14
prerank,O-acyltransferase activity (GO:0008374),0.40820854463343953,1.0286146395945024,0.4288389513108614,0.7374014284811327,1.0,3/30,7.18%,MBOAT2;MBOAT4;PLAAT1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.47396850533719304,1.0277823142057114,0.44419134396355353,0.7351429018608264,1.0,2/12,3.40%,SLC19A1;SLC25A25
prerank,actinin binding (GO:0042805),0.43349765142068086,1.0272350100579117,0.4367816091954023,0.7326475327669077,1.0,1/21,0.34%,CACNA1C
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4914837596135645,1.02343195502518,0.44536082474226807,0.7365239909364806,1.0,2/11,3.19%,PABIR1;PPP1R14A
prerank,protein phosphatase 1 binding (GO:0008157),0.4420702590818091,1.0231014438463388,0.4340344168260038,0.7334562431439585,1.0,2/21,2.09%,SMTNL2;AKAP11
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.3588526837740998,-1.022518152221167,0.4520255863539446,0.7881328628413624,1.0,8/28,15.76%,LRRK2;MAP2K6;MAPK14;MAP2K5;AKT1;PRKCG;MAPKAPK3;PRKAA2
prerank,translation elongation factor activity (GO:0003746),-0.42029897283516243,-1.0177297879374725,0.4547169811320755,0.7967596779919964,1.0,5/14,16.81%,EEF1A1;EIF5A;EIF5AL1;EEF1B2;EEFSEC
prerank,ATPase activator activity (GO:0001671),-0.3837219182400553,-1.017404576393698,0.4375,0.7933376802700215,1.0,7/20,18.30%,ATP1B3;TOR1AIP1;DNAJB2;DNAJC24;DNAJB6;DNAJC15;DNAJC10
prerank,protein heterodimerization activity (GO:0046982),-0.2574952417846144,-1.0165910980258306,0.4180602006688963,0.7914814614610477,1.0,60/178,25.85%,BMP6;EXT1;TCF4;TAF1;ITGA3;ZHX3;SDCBP;IRAK2;ARNT2;HEXA;BHLHE40;P4HB;BDKRB2;TOP2B;FZD4;ADRA1B;MCL1;HIF1A;KCNB1;NR4A2;ATF6;BHLHE41;IRAK3;ADD1;AHR;TCOF1;MEF2A;USF1;SAE1;RAN;CYBA;ATP1A1;RALGAPA2;FXR2;VAPA;UBA3;MICU2;SMC3;TLR4;USF2;LSM5;AGTR1;MICU1;IKBKG;YWHAH;SMC1A;CYBB;XBP1;TOP2A;SNX2;PAFAH1B1;ABCG4;TRMT112;YWHAE;MIGA1;BCL2L1;ATF3;RRAGC;NR4A1;TP53
prerank,PDZ domain binding (GO:0030165),-0.30659930971341987,-1.0128815503863198,0.42788461538461536,0.7966562856862677,1.0,18/61,12.74%,TGFBR3;DOCK4;CXADR;FZD2;SNTG2;ARHGAP29;SYNJ2;SLC22A4;USHBP1;ERC1;FZD4;ACOX1;FZD7;SLC22A5;TBC1D10A;F11R;CLCN3;CCDC88C
prerank,androgen receptor binding (GO:0050681),-0.3606478711991523,-1.0127163441758744,0.46938775510204084,0.7929563103358747,1.0,7/25,13.04%,FOXP1;DDX5;TMF1;PRKCB;KDM3A;NSD1;CALR
prerank,zinc ion binding (GO:0008270),-0.2405025228726158,-1.0106364375299888,0.3923444976076555,0.7942900664408138,1.0,82/293,20.85%,SMAD3;KDM7A;HDAC4;GLI2;PAM;PAPPA;EEA1;ENPP1;MYRIP;SHANK3;NPEPPS;SEC23A;SEC24D;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;TNFSF10;ACE;ENPP3;KDM5B;TET3;TES;SEC24A;SORD;ACER3;CHD3;RNPEP;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;DPP3;ZMYND8;IDE;SAMHD1;DNAJC24;NSD1;GCH1;ADAMTS3;RNF125;MDM2;NUDT12;CALR;RPS27;PLA2G15;ADH1A;MSRB3;ADAM33;GDA;SMPDL3A;TIMM13;TRIM8;SIRT2;FBXL19;SIRT3;ZCCHC4;TIMM8B;MT3;ZFYVE1;PIAS4;CTCF;CALB1;GLO1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;FNTB;ZDHHC15;TIMM9;THAP1;ENPP2;PHEX
prerank,kinase binding (GO:0019900),0.2781450510614501,1.0064374459206025,0.42839805825242716,0.7628584497397972,1.0,37/435,6.88%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;IL15RA;PTK2;RGCC;BCAR1;TNS2;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;ATP1A4;PTPN22;DOK7;ABI2;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;SCN5A;TNIP2;SYN1;SIK1;KIZ;CASP9;YWHAZ;EMP2
prerank,tau protein binding (GO:0048156),0.38387353429168214,1.0059628121433408,0.4262589928057554,0.7600108196350486,1.0,18/40,22.58%,MAP2;MARK1;ROCK1;TTBK1;SNCA;BIN1;MARK2;BRSK1;EP300;DCTN1;PRKAA1;CDK5;GSK3B;MARK4;STUB1;PPP2CB;PICALM;LGMN
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3975990711482507,1.0038984731928637,0.4342105263157895,0.7603722294990386,1.0,8/35,12.52%,PTK2;PEAK1;FRK;CSK;LYN;ABL2;TEC;SRC
prerank,RNA binding (GO:0003723),-0.2168208596018244,-1.0021372667852,0.4,0.81190315611746,1.0,397/1321,26.57%,CELF2;MSI2;SAMD4A;DCN;ROCK2;BICC1;AHNAK;NSA2;FNDC3B;RBFOX2;HOXB6;STRBP;MACF1;VIM;RBMS2;DIAPH1;MBNL1;ANXA2;MYO18A;GOLGB1;LBR;ASCC3;EZR;CAST;PLEC;RPS14;CMSS1;LARP4B;DDX5;RBM47;DDX60;RBM20;RPL9;TUT4;MOV10;SERPINH1;RPS12;THRAP3;TUT7;LUC7L;EDC3;P4HB;RPL41;SRRM2;RPS20;CAVIN1;SIDT1;NUDT4;HDLBP;TES;DDX6;SSBP1;CHD3;NYNRIN;RPL18A;RARS2;STAT3;AFF2;RPS13;RPS19;CPEB2;RPS23;SRBD1;RPS4X;CCDC9;LARP1B;TFRC;TEP1;NOCT;SIDT2;ZYX;TMSB4X;IFIT2;RPS11;RTF1;IGF2BP2;ARHGEF1;POLR2A;EIF4A1;TPT1;UTP14A;RPL13;RC3H2;NOVA2;ACO1;MKRN2;SMG6;MYH10;SON;RPL18;ZFR2;FAM120A;SORBS2;COL14A1;RPS9;EIF2S2;EEF1A1;DENR;RPL34;RPL32;REXO4;OAS2;NAF1;PINX1;PCBP2;KRR1;RBM33;VIRMA;UTP11;CTNNA1;RPL27A;RPS8;IFIT3;RPL12;ATXN2;IFIT1;FAM120C;RPL37;SAMHD1;KARS1;USO1;ZC3H12A;RBM10;FKBP4;DHX32;EIF5A;ANXA7;MTPAP;NXF1;NDUFV3;TDRD3;NOP58;SLC3A2;RPL11;RPS18;RBM42;ANXA11;PUM1;ERI3;EIF4G3;ADD1;TRIP6;PFN1;SUCLG1;CKAP4;CARS1;RPL39;RPS5;RPS16;STRAP;RPL24;NME1;LRRFIP1;RPS15A;HELZ;ELP1;UTP6;MBNL2;CPEB3;ISG20L2;ACTN1;GRSF1;CHD2;TCOF1;TENT5A;NOVA1;YBX3;RPL28;SRSF10;FNDC3A;RPS24;RAN;SF3B6;CALR;RPS27;RPL14;DDX49;RPL26;FAU;LARP1;LRRC47;MRPS7;TXN;EIF4A2;CS;SARS1;TUBA1B;RAMAC;RPL10;GEMIN5;PPIA;BYSL;ENO1;RPL7;HSP90AB1;SNIP1;MRPS24;DDX24;SLTM;PRPF3;MAZ;FXR2;SCG3;CHCHD1;EIF5B;RPL10A;AGFG1;ZCCHC17;NUP98;RPL22;RBM34;RPS15;RPS6;XPOT;SPATS2L;RPL23;RPL17;TYW5;GANAB;PDIA3;SNRPF;SEC23IP;G3BP1;MRPL15;XRN1;NKRF;CEBPZ;SLIRP;HMGB2;EBNA1BP2;ELAVL1;RPL31;PPHLN1;PNPT1;RNASEL;TRMT2A;TRNAU1AP;TRMT10B;TNRC6A;SRSF2;SNRPD1;SNRPD2;SMG5;ELAC2;HNRNPUL2;HNRNPAB;RPS25;NOL12;SNRNP40;PSIP1;TOE1;TPR;RPL15;RPSA;PNLDC1;LSM5;DYNC1H1;RPS7;SRSF6;RRP8;KCTD12;PARK7;PSMD4;EIF4E2;RPL38;MRPL39;RPLP0;HSP90B1;RPL27;CSDC2;PTBP3;ZFP36L2;HMGN5;EIF1B;AGO1;PPARGC1A;UNC50;VCP;PABPC4L;NAT10;LGALS1;CANX;TEFM;SF3B5;TFB1M;ESF1;RCC1L;POLRMT;PNO1;RRBP1;NONO;SMC1A;UBTF;ERH;TENT4B;RPL36A;DDX55;DICER1;DRG2;RRP12;FARSA;USP36;ZC3H18;HNRNPL;CCDC86;SRPK1;RPP38;SAMSN1;MRPL12;MRPL1;PURG;RRP7A;PCBP4;FTSJ3;TCF20;RBBP6;SEC61B;SRF;NELFCD;RPS26;DZIP3;UTP23;ASS1;TOP2A;RPS27L;LRRC59;SRSF5;WRAP53;NUDT16;TUBB4B;LYAR;HSPA9;RPL35A;ALDOA;WBP11;MRPS26;DHX34;FIP1L1;DSP;TRUB2;CSDE1;DNAJC21;HELZ2;EXOSC7;SAMD4B;APEH;DHX8;RDX;CCDC47;SF3A3;BRCA1;RPL8;USP10;YWHAE;RPL36;MTHFSD;EIF3B;POLR2G;CDK11B;ALKBH5;CELF5;FASTKD5;ZNF326;MEX3A;LSM7;SRSF11;RRS1;SRPK2;RPS3;PEG10;ZBP1;S100A16;DNAJC2;ACIN1;MRPL4;HNRNPF;RACK1;HNRNPA0;ZNF106;CPNE3;NUDT1;RPL13A;ZC3H12B;FBL;POP1;NHP2;MRPL21;EIF2AK4;ABCF1;MRPL54;PUF60;G3BP2;RPUSD4;DDX54;CLK3;RBMX2;PEBP1
prerank,retinoic acid receptor binding (GO:0042974),0.4393817639541333,1.0019016528114115,0.47035573122529645,0.7605900266206842,1.0,7/17,17.06%,TACC1;ACTN4;ARID5A;NCOA6;MED1;CNOT1;NRIP1
prerank,protein kinase binding (GO:0019901),0.2760689755069329,1.001624795678611,0.45195729537366547,0.7574144607171819,1.0,52/480,8.76%,PTPRK;PDGFRB;CSPG4;UTRN;LIMS1;SLC12A2;PRKCSH;IL15RA;PTK2;RGCC;PKN1;BCAR1;PRKAR1B;FERMT2;RND3;SPRED1;AGAP2;WAS;PTN;FOXM1;DOK7;SH2B3;PKIA;GRM5;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;TRIB2;SCN5A;ITGB1;TNIP2;SYN1;PRKAR2B;RYR2;SIK1;APPL1;KIZ;CASP9;YWHAZ;EMP2;IRS1;CDKN1A;PPP1CC;PRKAR2A;GRK5;SHC4;RAB11FIP2;CSK
prerank,SUMO transferase activity (GO:0019789),-0.40545092344984557,-1.001432596577829,0.4527272727272727,0.8094921290226598,1.0,5/16,24.62%,HDAC4;MDM2;CBX4;PIAS4;PIAS3
prerank,heme binding (GO:0020037),0.3447688347765177,1.0007680247952417,0.41935483870967744,0.7554070986231638,1.0,1/65,0.12%,GUCY1B1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4208961856210363,1.0003167936178523,0.4369918699186992,0.7526463556998615,1.0,10/23,18.10%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPU;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,protein kinase C binding (GO:0005080),-0.3153320226316235,-1.0001008442305956,0.5138248847926268,0.8090842367714609,1.0,12/43,13.94%,PDLIM5;HDAC7;CAVIN2;ADAM9;HDAC9;PARD6G;PRKCB;TOP2B;HINT1;TRPV4;HDAC5;CAVIN3
prerank,nuclear export signal receptor activity (GO:0005049),-0.44068137303019184,-0.9975576392388383,0.4849056603773585,0.8113957502301319,1.0,7/11,30.29%,RAN;NUP214;XPO4;RANBP17;EIF4ENIF1;CSE1L;XPO5
prerank,potassium:proton antiporter activity (GO:0015386),-0.4449677128297873,-0.9969774411434755,0.481216457960644,0.8086914308482137,1.0,3/10,17.51%,SLC9A2;SLC9A9;SLC9A1
prerank,histone deacetylase binding (GO:0042826),0.3333954275102257,0.9967216664680371,0.44651162790697674,0.7560928446577405,1.0,5/88,3.98%,MEF2C;HEY2;PRDM1;PKN1;MIER1
prerank,GTP binding (GO:0005525),0.30103938037652345,0.9952341792724269,0.4597222222222222,0.7553236205043928,1.0,17/172,8.86%,RASL12;REM1;RERG;RND3;AGAP2;RRAD;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,cytokine receptor binding (GO:0005126),-0.2827801401047768,-0.9951609080760471,0.42857142857142855,0.8091215795405867,1.0,16/83,12.03%,TGFBR3;SMAD3;IL6R;IL6ST;CSF1;SOCS2;VEGFD;SDCBP;VEGFC;CXCL12;FKBP1A;ERAP1;USP15;IL18;TRIP6;CCL25
prerank,amyloid-beta binding (GO:0001540),0.3302764588623926,0.9940235282461937,0.4493464052287582,0.7540085629027375,1.0,13/79,10.24%,CLSTN1;APBB2;FZD6;LDLRAP1;LDLR;MSR1;GRIA2;CHRNA7;ACHE;ITM2B;GRIN2B;CACNA1A;APBA2
prerank,thyroid hormone receptor binding (GO:0046966),0.39775171699391026,0.990181284751195,0.4553734061930783,0.7583425023803002,1.0,10/28,18.02%,NCOA3;TACC1;MED13;ARID5A;NCOA6;MED1;MED4;GTF2H1;HMGN3;MED30
prerank,microtubule binding (GO:0008017),0.2926039354298141,0.9888967251471539,0.47304582210242585,0.7572411895202379,1.0,32/222,11.88%,SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;SVBP;FGF13;NAV3;GAS8;CLASP2;MAPRE2;TPPP;STIM1;KIF26B;HOOK3;FAM161A;MAP4K4;CLIP2;NUSAP1;KIF3A;UXT;CAMSAP3;TOGARAM2;MACO1;TPGS1;CCDC66;KIF20A;KIF5C;APC;KIF3C
prerank,E-box binding (GO:0070888),0.38278368252890765,0.9870447928693805,0.4634146341463415,0.7574063968000496,1.0,6/34,11.05%,ZEB1;TCF15;SCRT2;SREBF2;MITF;SNAI2
prerank,retinoic acid binding (GO:0001972),-0.4332389838258659,-0.9866049094976239,0.49809885931558934,0.8264226235192579,1.0,3/12,26.10%,CYP26B1;RARA;RXRA
prerank,magnesium ion binding (GO:0000287),0.30961738735214817,0.9849630801294214,0.47181008902077154,0.7578503542022701,1.0,22/135,11.79%,MAP3K20;MAP3K5;SNRK;MARK1;NUAK2;CIB3;CDC42BPA;UBA2;STK38L;SNCA;TPPP;SIK1;PAPOLA;MTHFD2;STK3;MARK2;NEK6;DYRK3;ABL2;BRSK1;SRR;NLK
prerank,galactosyltransferase activity (GO:0008378),-0.4366491710973522,-0.9841852644875426,0.5027829313543599,0.8285311715972059,1.0,2/11,5.00%,B4GALT1;A4GALT
prerank,protein phosphatase 2A binding (GO:0051721),-0.35642733132487037,-0.9836214386411085,0.505091649694501,0.8258579992366355,1.0,7/23,16.95%,FOXO1;CTTNBP2NL;MFHAS1;PTPA;DAB2IP;SPHK1;SMG5
prerank,ankyrin binding (GO:0030506),0.4314973032354082,0.9834457931479486,0.4939516129032258,0.7570944844198364,1.0,5/19,7.38%,SPTBN1;SPTB;SCN5A;KCTD6;CACNA1D
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3256845944686033,-0.9828250069538436,0.501123595505618,0.8238017498964778,1.0,8/34,16.17%,IQGAP1;IGF2;CALM2;ALS2;IRGM;DBF4;PARP16;CALM1
prerank,poly(U) RNA binding (GO:0008266),0.41852269250789914,0.9825064830413821,0.47540983606557374,0.7553891447389374,1.0,9/20,18.10%,RBMS3;SSB;RBMS1;PABPC4;DAZAP1;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,alpha-actinin binding (GO:0051393),0.4055144115457855,0.9813257822439285,0.482421875,0.7542348620875052,1.0,4/24,9.02%,CACNA1C;PDLIM1;CACNA1D;PKD2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.45404912745816695,0.9775469413696458,0.5031847133757962,0.7580873114745407,1.0,2/12,6.79%,ATP2A3;BCL2L13
prerank,methylation-dependent protein binding (GO:0140034),-0.296652927068248,-0.9774780851497219,0.5035294117647059,0.8331083154341823,1.0,29/57,38.25%,KDM7A;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3;RBBP5;JMJD7;CBX8;ATRX;UHRF1;KDM4A;KMT2E;PHF2;PHF1
prerank,antiporter activity (GO:0015297),-0.3746342386608126,-0.9762697527811454,0.4751908396946565,0.8320039771520287,1.0,5/20,16.02%,TMEM241;CLCN3;ATP1A3;SLC35D2;SLC35E4
prerank,peptidoglycan binding (GO:0042834),-0.44135417189475307,-0.9751053732846985,0.5190114068441065,0.8310013785894343,1.0,2/10,9.38%,NOD1;PGLYRP1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.45624697570099326,0.9745401976192161,0.48088531187122735,0.760448111488872,1.0,5/12,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;TRIM37
prerank,cytokine activity (GO:0005125),-0.2574173209863721,-0.9712218743526483,0.5277777777777778,0.8366977162144391,1.0,19/131,12.09%,BMP6;WNT4;BMP7;IL15;WNT6;BMP4;CSF1;WNT9A;TNFRSF11B;IL16;CXCL12;WNT5A;CCL15;CCL14;IL33;IL18;TGFB1;CCL25;WNT5B
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.39567910438985726,0.9702629070023819,0.4893203883495146,0.7651846932534903,1.0,5/29,5.46%,SLC1A5;SLC1A4;SLC19A1;SLC26A1;SLC25A13
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.4369505881203265,0.9702367479948999,0.4883227176220807,0.7617453499663853,1.0,2/14,6.79%,ATP2A3;BCL2L13
prerank,calcium-activated potassium channel activity (GO:0015269),0.453390642395588,0.9683911738203438,0.47789473684210526,0.7618620076815252,1.0,3/11,14.12%,KCNMB1;KCNMA1;KCNU1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.45151157004377196,0.9637576217121557,0.475,0.7673435637774176,1.0,4/11,12.93%,ITPR1;RYR2;RYR3;RASA3
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4372048220418384,-0.9620250918396936,0.5261194029850746,0.8551637536010377,1.0,6/10,31.35%,BRCA2;NAA40;USP22;HAT1;ATF2;NAA60
prerank,double-stranded RNA binding (GO:0003725),-0.2891771026378288,-0.9617967338733258,0.5241545893719807,0.851714193496095,1.0,16/70,14.30%,STRBP;VIM;MBNL1;DDX60;SIDT1;TFRC;SIDT2;EIF4A1;RC3H2;ZFR2;OAS2;SLC3A2;LRRFIP1;ACTN1;TUBA1B;HSP90AB1
prerank,cell adhesion mediator activity (GO:0098631),0.4019041494645247,0.9612924287723215,0.48490945674044267,0.7688024780974069,1.0,7/24,13.51%,JAM3;LRRC4C;ESAM;CNTN4;CNTN6;PLXNB3;DSCAM
prerank,methylated histone binding (GO:0035064),-0.2903271250200719,-0.9612918940051118,0.5232273838630807,0.8489381517703953,1.0,22/62,28.15%,KDM7A;TAF1;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;CHD5;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;L3MBTL1;ZCWPW1;CBX2;MBTD1;MORC3
prerank,clathrin adaptor activity (GO:0035615),-0.3904154973965714,-0.9587368390926789,0.5153374233128835,0.851263431532521,1.0,3/15,5.05%,DAB2;STON2;AP2A2
prerank,chemokine activity (GO:0008009),-0.3237159767028129,-0.950934135760833,0.5202558635394456,0.8659798625630633,1.0,19/31,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;CX3CL1;CCL28;CCL5;CCL11;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.339335323472925,-0.9473483415646603,0.5212765957446809,0.8709835583512324,1.0,11/27,25.64%,RNF19A;RNF144B;RNF125;PPARA;ANKIB1;UBE3D;RNF217;RNF144A;RNF19B;FOXL2;PRKN
prerank,death receptor binding (GO:0005123),-0.3836956935652957,-0.9459466923916978,0.5546875,0.8705456566219317,1.0,9/15,39.47%,DAB2IP;BID;RIPK1;EDA;NTF3;MYD88;FADD;PIDD1;CASP8AP2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4347682187401339,0.9438089698178187,0.4866666666666667,0.7989158547560354,1.0,3/12,8.28%,SLC5A1;SLC2A6;SLC2A3
prerank,DNA secondary structure binding (GO:0000217),0.37854660774363996,0.9435574657236322,0.5185909980430529,0.7959000334763687,1.0,1/31,0.63%,MEF2C
prerank,ubiquitin protein ligase activity (GO:0061630),-0.2294825249929859,-0.943550324186566,0.648,0.8724280820086084,1.0,49/228,16.96%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;UBE4B;RNF125;MDM2;TRIM63;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,gated channel activity (GO:0022836),-0.3894716070784953,-0.9413931301169276,0.5387523629489603,0.8734377298692346,1.0,3/14,11.08%,PIEZO2;PIEZO1;TMC6
prerank,mRNA binding (GO:0003729),-0.23003544374335808,-0.9400558269755964,0.6422413793103449,0.8725567658791041,1.0,60/249,19.27%,CELF2;SAMD4A;RBFOX2;RBMS2;RPS14;LARP4B;DDX5;RBM47;RBM20;LUC7L;EDC3;RPL41;SRRM2;HDLBP;DDX6;NYNRIN;RPS13;CPEB2;SRBD1;NOCT;IGF2BP2;EIF4A1;RC3H2;NOVA2;ACO1;MYH10;EIF2S2;DENR;PCBP2;ZC3H12A;PUM1;EIF4G3;RPS5;CPEB3;GRSF1;NOVA1;YBX3;SF3B6;CALR;RPL26;LARP1;MRPS7;AUH;GEMIN5;RPL7;SNIP1;FXR2;NUP98;G3BP1;ELAVL1;RNF40;HNRNPAB;TPR;RPS7;SRSF6;PARK7;TYMS;CSDC2;PTBP3;PABPC4L
prerank,GABA receptor activity (GO:0016917),0.4000304985967565,0.9393382240577146,0.5063025210084033,0.8004001328281984,1.0,7/21,20.89%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABBR2;GABRB2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3715212123558603,-0.93914057528856,0.5618661257606491,0.8706970186285385,1.0,2/16,2.95%,SLC26A7;SLC26A2
prerank,acetyltransferase activity (GO:0016407),-0.3241671983331468,-0.9373035616153342,0.5448979591836735,0.8712478127099177,1.0,8/31,21.27%,KAT6B;KAT2B;SPHK1;PAFAH2;ELP3;NAT10;SAT1;NAA80
prerank,mannose binding (GO:0005537),-0.3992729364293269,-0.9369019326501407,0.5449330783938815,0.8683235249196086,1.0,6/12,46.36%,LMAN1;CLN5;ACR;COLEC11;LMAN1L;CLEC4D
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4024365443992132,0.936396714064547,0.5416666666666666,0.8026312264939784,1.0,1/18,1.67%,RDH5
prerank,calcium channel inhibitor activity (GO:0019855),-0.41202712494713667,-0.9340623629875268,0.5446096654275093,0.8712098775917242,1.0,5/11,17.40%,CALM2;FKBP1A;MCUB;CALM1;SLC30A1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.32329063560766186,-0.933565929720103,0.5495689655172413,0.8685046537792779,1.0,13/32,24.21%,SLC6A6;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC43A1;SLC36A1;SLC1A1;SLC38A1;MFSD12
prerank,small GTPase binding (GO:0031267),0.28822155136344396,0.930365630575834,0.5605633802816902,0.810774096978958,1.0,29/170,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,microtubule plus-end binding (GO:0051010),0.39052119536127655,0.9300336137154589,0.5203252032520326,0.8078626302059971,1.0,9/20,18.78%,CLASP2;MAPRE2;STIM1;CLIP2;APC;DCTN1;CLIP1;DST;KNSTRN
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.37264945215435097,-0.929150518836045,0.5666041275797373,0.8753883052241989,1.0,8/14,37.73%,PRORP;ELAC2;RPP38;TSEN2;POP1;TSEN34;RPP21;RPP40
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3910369834074119,-0.9277105909891038,0.5563380281690141,0.8749362997487135,1.0,6/12,20.83%,CNOT7;NOCT;CNOT8;TOE1;PNLDC1;PAN3
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.3985500589744533,0.9243695690416505,0.5394456289978679,0.8152609291081658,1.0,6/17,15.63%,CLP1;AK8;AK7;AK5;AK4;AK3
prerank,glucose transmembrane transporter activity (GO:0005355),0.3985494850940908,0.9241306804736105,0.4924731182795699,0.8122731956257018,1.0,3/17,8.28%,SLC5A1;SLC2A6;SLC2A3
prerank,U6 snRNA binding (GO:0017070),0.42125410499270977,0.9230765887613631,0.5154004106776181,0.8106878134474259,1.0,5/14,17.68%,LSM3;SART3;LSM8;LSM2;LARP7
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.22449581301922597,-0.9230299822895822,0.72,0.8819588669433635,1.0,49/232,16.96%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;KCMF1;ASB2;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF3;SH3RF2;AMFR;BIRC3;RC3H2;NHLRC3;MKRN2;RNF185;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;RNF125;MDM2;TRIM63;CBX4;TRIM35;BRAP;RNF181;TRIM39;DTX1;TRIM17;NEURL2;RNF115;RNFT2;WWP1;ANKIB1;RNF187;ASB1;UBR4;PELI1;UBE3D
prerank,protein homodimerization activity (GO:0042803),0.25448602552126015,0.9224554408220356,0.6804123711340206,0.8083432488952993,1.0,66/590,10.38%,ANO1;TRPC6;CASQ2;IMPA2;PTH1R;FAP;RBPMS;MAP3K5;SYNE1;RBPMS2;MTCL1;RDH5;TRIM9;MYH9;DCLRE1B;ERBB4;PLD6;PIP4K2A;ECE1;MID2;ABCD2;BCL2L10;GUCY2D;ADCY8;PDCD10;CRPPA;PEX7;CARD9;ACTN4;TFAP2B;NTRK2;TPPP;SFPQ;CHRNA7;APPL1;PSMF1;RCHY1;SUPV3L1;PADI2;RIPK2;TYR;PTPRT;HMGCS1;ACHE;DCK;STC2;TENM4;CORO1A;RAB11FIP2;ARNT;CIP2A;PKD2;NR2F2;MSH3;PDGFB;ZDHHC2;TARBP2;CR2;CNOT9;MYOM1;EFEMP2;GNPTG;DARS2;HIP1;TBX18;DGKD
prerank,glutamate receptor binding (GO:0035254),-0.36762725828271753,-0.9224413031128297,0.5510597302504817,0.8794434893764128,1.0,6/17,17.11%,SHANK3;GNAS;CAMK2A;SHISA7;HOMER1;HOMER3
prerank,phosphatase binding (GO:0019902),0.2963332283412019,0.9196808639666003,0.5598227474150664,0.8102266092652287,1.0,8/105,5.43%,ITGA1;MAP3K5;PTK2;PIK3R1;SPRED1;MYO16;JAK1;ROS1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4409442522810974,0.9176075663759572,0.535483870967742,0.8106139384721179,1.0,6/10,10.18%,PRKAR1B;PKIA;CXCL10;PRKAR2B;PRKAR2A;PRKAR1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3635251084484537,-0.917042904302254,0.5613026819923371,0.8841384298426335,1.0,5/16,15.25%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3635251084484537,-0.917042904302254,0.5613026819923371,0.8841384298426335,1.0,5/16,15.25%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,5'-3' exonuclease activity (GO:0008409),0.4281828733381065,0.9168642739031709,0.5205761316872428,0.8086890055661556,1.0,3/14,10.41%,DCLRE1B;XRN2;TRIR
prerank,acylglycerol lipase activity (GO:0047372),-0.39680230010422163,-0.9156314993433992,0.5732600732600732,0.8835854424352722,1.0,3/11,13.01%,MGLL;LIPE;ABHD16A
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.41621436869751094,0.9150511045136371,0.5119825708061002,0.808547730406212,1.0,1/12,1.10%,CDK6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3318699238040923,0.9149939188275747,0.5642361111111112,0.8052500178378664,1.0,4/57,5.41%,COX4I2;NDUFA4L2;UQCRFS1;NDUFB2
prerank,snRNA binding (GO:0017069),0.35197263396665623,0.9138843455586946,0.5626134301270418,0.8039188896490789,1.0,13/42,17.68%,HEXIM1;NCBP2;LSM10;SART3;RBM7;HNRNPU;LSM8;COIL;PRPF31;SF3B3;SNRPD3;LSM2;LARP7
prerank,growth factor receptor binding (GO:0070851),0.29752622064054274,0.91115308663205,0.5694444444444444,0.8058565233269424,1.0,12/95,10.21%,PDGFRB;GLMN;LINGO1;ERBB4;IL1B;FGF2;IL4;FGF10;IL12RB1;PDGFB;CNOT9;HIP1
prerank,ribosomal large subunit binding (GO:0043023),0.42960437046254596,0.9106090088026185,0.5323590814196242,0.803554781217219,1.0,4/11,11.18%,CPSF6;NMD3;MALSU1;EIF6
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.42178961980287927,0.9070718811723048,0.5733041575492341,0.8065861498378117,1.0,5/13,13.49%,TRMT5;TRMT1;THUMPD2;TRMT11;TRMT10C
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3009897513149401,-0.9067235421029936,0.604494382022472,0.8995251182924275,1.0,12/37,20.75%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.39751313062458854,-0.9066790085548606,0.5841392649903289,0.8919776984194343,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,adenyl nucleotide binding (GO:0030554),-0.39751313062458854,-0.9066790085548606,0.5841392649903289,0.8919776984194343,1.0,6/11,28.91%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,fatty acid synthase activity (GO:0004312),-0.39711145355990396,-0.9051697486891958,0.5830039525691699,0.8917956012294507,1.0,3/10,23.82%,ELOVL7;ELOVL1;OXSM
prerank,nuclease activity (GO:0004518),-0.285741733298126,-0.9049844579837083,0.6470588235294118,0.888363286089932,1.0,12/52,17.38%,ENPP1;RNASE4;N4BP2;ERCC5;REXO4;SAMHD1;ZC3H12A;DNASE1L1;NME1;ISG20L2;RNASEL;RNASE12
prerank,palmitoyltransferase activity (GO:0016409),0.35970575827383844,0.9047531171806477,0.5632183908045977,0.807560699870265,1.0,8/28,13.52%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.44170096559032485,0.9011610255580595,0.5615212527964206,0.8110362981621922,1.0,2/10,4.44%,SLCO3A1;SLCO5A1
prerank,phosphatase inhibitor activity (GO:0019212),0.37483996413813286,0.8965463168519321,0.5733082706766918,0.816166149615146,1.0,9/20,22.02%,PTN;SET;URI1;MGAT5;CABIN1;SAG;LMTK2;STYXL1;BOD1L1
prerank,nuclear receptor binding (GO:0016922),-0.244856050517137,-0.8964405706236691,0.7158774373259053,0.9034809873627265,1.0,21/111,13.14%,SMAD3;FOXP1;LCOR;ESR1;DDX5;TACC2;TCF7L2;LEF1;TAF1;TMF1;THRAP3;PRKCB;STAT1;HIF1A;NR4A2;MMS19;KDM3A;NSD1;TRIP6;CALR;PPID
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.28973986908051574,-0.8964108651162893,0.6682464454976303,0.8997893185398401,1.0,8/46,11.95%,EXT1;LARGE1;HEXA;HEXB;MGAT1;B3GALNT1;MGAT2;EXTL2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.37333297266918897,0.8962682556455215,0.5456389452332657,0.8100639722687035,1.0,2/21,3.46%,CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.37333297266918897,0.8962682556455215,0.5456389452332657,0.8100639722687035,1.0,2/21,3.46%,CDK6;CDK15
prerank,histone demethylase activity (GO:0032452),-0.3164454572721716,-0.8939794788120884,0.6273291925465838,0.9012141377723228,1.0,6/27,17.21%,KDM7A;KDM5B;JARID2;KDM3A;KDM6B;FBXL19
prerank,protein tyrosine kinase activity (GO:0004713),0.28890009877719464,0.8936346107129418,0.5991189427312775,0.8117538279393185,1.0,23/108,12.64%,PDGFRB;ROR1;PTK2;PEAK1;FRK;MERTK;ERBB4;AXL;JAK1;RYK;ROS1;NTRK2;TTBK1;CSK;LYN;EPHA2;ABL2;HIPK1;EPHA10;TEC;EPHB1;SRC;FGFR3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3962785843705713,0.8934998844801972,0.5798816568047337,0.8087145184407858,1.0,3/15,10.26%,PIK3R1;SOCS5;SOCS6
prerank,telomerase RNA binding (GO:0070034),-0.33611369940276004,-0.887112656542087,0.6396039603960396,0.9123522603858577,1.0,10/22,27.11%,TEP1;SMG6;NAF1;PINX1;XRN1;SMG5;TENT4B;WRAP53;NHP2;SNRPB
prerank,mRNA methyltransferase activity (GO:0008174),0.41948713463860066,0.8870313649203877,0.570230607966457,0.8168822130923035,1.0,4/12,17.92%,TRMT61A;RNMT;TRMT10C;NSUN2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.40426111173446266,-0.8841711640059281,0.6139359698681732,0.9149426001486032,1.0,3/10,14.53%,SHANK3;GNAS;SHISA7
prerank,MHC class II protein complex binding (GO:0023026),-0.3848903175208891,-0.8841374033646194,0.6126629422718808,0.9112514631845714,1.0,4/11,24.43%,ANXA11;HSP90AB1;CD81;YWHAE
prerank,phosphatase activity (GO:0016791),-0.2540647835111877,-0.884068574170385,0.6666666666666666,0.9076773525017732,1.0,31/73,29.87%,PLPP3;PTPRJ;ALPL;DUSP12;NOCT;PPP1CB;DUSP16;PXYLP1;PLPP1;EPHX2;PGAM5;LPIN3;PGP;DUSP10;DUSP23;LHPP;PLPP4;CILP;NUDT16;DUSP15;INPP5K;NT5C;PPP5C;CILP2;PLPPR4;ACP3;PLPP2;DUSP26;PPP1CA;DUSP8;DUSP4
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.41722164481169793,0.8833760172706058,0.5792811839323467,0.8200387384998488,1.0,1/13,0.19%,PDGFRB
prerank,transferrin receptor binding (GO:1990459),0.4177113467994794,0.8830346541988584,0.5603448275862069,0.8173562363866391,1.0,1/10,2.07%,RGMA
prerank,GTPase binding (GO:0051020),0.2698499721155825,0.881876566905523,0.6778242677824268,0.816309376498723,1.0,31/195,11.50%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;SPTBN1;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;PEX5L;IFT20;GGA3;ATG16L1;RIC1;HACE1;LZTR1;ARHGDIB;KCTD13;MTSS2;NCKAP1;BICD2;KIF3A;BRAF;RANGRF;DENND10;PAK1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3007032382662248,-0.8815225664766247,0.6391304347826087,0.909524832332442,1.0,14/33,25.64%,RNF19A;RNF144B;RNF185;RNF125;PPARA;ANKIB1;UBE3D;PARK7;RNF217;RNF144A;RNF19B;FOXL2;RPS3;PRKN
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.41878220526376814,0.881339434130132,0.5643340857787811,0.8142111426704365,1.0,2/10,6.31%,OTUD5;DESI2
prerank,nucleosomal DNA binding (GO:0031492),-0.3254572235640113,-0.8804830040157371,0.6106870229007634,0.9078544219010769,1.0,6/21,22.86%,H3-3A;HDAC1;ACTB;SMARCC1;MBD2;SMARCA4
prerank,copper ion binding (GO:0005507),-0.27892980247701704,-0.8765312507688129,0.6743119266055045,0.9124163170690197,1.0,5/42,7.43%,MOXD1;PAM;ATOX1;LACC1;P2RX4
prerank,GTPase activity (GO:0003924),0.2633360451812871,0.8765112055728479,0.6985195154777928,0.8197071336888632,1.0,20/192,8.86%,RASL12;RERG;RND3;AGAP2;GNAZ;RAB8B;RAC3;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;RAB38;GNA12;RNF112
prerank,histone methyltransferase activity (GO:0042054),-0.29385605285623473,-0.867472561468906,0.6582278481012658,0.9273097947124093,1.0,5/32,10.02%,SMYD3;SETD7;KMT5A;CARM1;EHMT1
prerank,methyl-CpG binding (GO:0008327),0.357943233899585,0.86547369576932,0.6047904191616766,0.8365805387222679,1.0,4/22,10.73%,CDX1;MECP2;LHX4;PRMT1
prerank,peptidase activator activity (GO:0016504),-0.32558789983520303,-0.8651898895301373,0.6598360655737705,0.928164452840512,1.0,6/22,22.40%,CAV1;PSME2;PCOLCE;PSME3;VCP;CLPX
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3471252563279921,-0.8641155677223424,0.647410358565737,0.9266664007364221,1.0,8/16,26.83%,CD38;MACROD1;TDG;ADPRS;NEIL3;RPS3;NEIL1;NTHL1
prerank,translation initiation factor activity (GO:0003743),-0.28686697994270455,-0.8629001057338755,0.6586433260393874,0.9254459914255223,1.0,16/36,30.58%,EIF4A1;EIF2S2;EIF4G3;MTIF3;EIF4A2;EIF5B;EIF2B2;EIF4E2;EIF1B;EIF2B5;EIF3B;EIF3H;EIF2B4;EIF2D;AGO2;EIF3D
prerank,RNA stem-loop binding (GO:0035613),-0.37082066605228087,-0.8625841439037352,0.6407407407407407,0.9224667221905639,1.0,4/12,12.43%,RC3H2;MYH10;ZC3H12A;CPEB3
prerank,ribonuclease activity (GO:0004540),-0.26157892346437117,-0.8592371253528287,0.7078384798099763,0.9258040670590534,1.0,14/56,20.39%,CNOT7;RNASE4;NYNRIN;SMG6;SAMHD1;ZC3H12A;ERN1;INTS11;EXOSC5;RNASEL;ELAC2;RNASE12;AGO1;DICER1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.3689316263825355,-0.8588742443588342,0.6491862567811935,0.9228301759150312,1.0,5/12,20.22%,MTPAP;TENT5A;PAPOLB;TENT5C;TENT4B
prerank,O-methyltransferase activity (GO:0008171),-0.39429422081403653,-0.858148733672969,0.6416184971098265,0.9206393155605292,1.0,4/10,32.58%,CMTR1;FTSJ3;ASMT;BCDIN3D
prerank,chemoattractant activity (GO:0042056),-0.30255278507531663,-0.8572899846117036,0.6614173228346457,0.9186433841860999,1.0,4/26,6.30%,BMP4;VEGFD;VEGFC;CCL15
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3911021310702824,0.856832540130054,0.5847107438016529,0.8483998307590159,1.0,2/13,8.23%,SREBF2;ECI1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4143417853792986,0.8563152290447531,0.5847826086956521,0.8460407788882306,1.0,5/10,19.44%,SETMAR;SETD3;NSD2;NSD3;SETD5
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2022321354894186,-0.8532774601983003,0.9012875536480687,0.9231917479640338,1.0,95/269,28.98%,SNCAIP;SMAD3;EGFR;SMAD6;FOXO1;FHIT;SNX9;SMAD7;SKI;PARP9;ARRB1;STAT2;TNFRSF1B;IKBKE;TXNIP;MFHAS1;STAT1;HSPA5;ACTG1;POLR2A;FZD4;DTX3L;HGS;TRIOBP;HIF1A;PCBP2;BECN1;CASP8;ARRDC1;PML;PATZ1;RPL11;CUL4A;MDM2;RELA;SLC22A18;UBB;CALR;PRKACB;ELOB;TUBA1B;HSP90AB1;NEDD8;WASHC1;DTX1;FZD8;RPL23;TMBIM6;CBS;RNF40;SMG5;RIPK1;GABARAPL1;NFKBIA;ERLIN2;EIF4E2;NPLOC4;TRIB1;PPARGC1A;VCP;PIAS4;IKBKG;CDK5RAP3;UBE2L6;RFFL;UBXN1;CUL5;WRAP53;HSPA9;USP2;CHEK2;RNF8;BRCA1;YWHAE;PRKN;TRIP4;TP53;BAG5;KCNH2;SCAMP3;BCL10;ATXN3;FZD5;PRR7;TRIB3;HSPA1B;CLU;SLF1;ATP6V0C;TNK2;LAPTM5;BAG1;SMAD2;ISG15;JUN
prerank,motor activity (GO:0003774),0.2993652400574447,0.8469008930879538,0.6775862068965517,0.8597959621788709,1.0,14/60,15.94%,STARD9;MYH9;KIF26B;MYO6;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,ribosome binding (GO:0043022),0.3151293453245334,0.846069831700089,0.6596491228070176,0.8578595537576639,1.0,17/46,21.58%,CPEB1;MRPS27;YTHDF3;SRP72;EIF3C;NCLN;EIF6;GTPBP6;CPEB4;C1QBP;FMR1;NAA15;OXA1L;EEF2;SEC61A2;SRP68;EIF2S1
prerank,Toll-like receptor binding (GO:0035325),-0.363356209939628,-0.8455666919678829,0.663003663003663,0.9346309325873967,1.0,7/11,43.79%,DAB2IP;MYD88;CD36;TLR6;TLR1;TLR2;S100A9
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3913569199805351,0.8438328889298263,0.6252545824847251,0.8583090131187489,1.0,3/11,12.99%,PRMT1;PRMT3;PRMT7
prerank,water transmembrane transporter activity (GO:0005372),-0.3624763018026617,-0.8435540661201308,0.6934579439252336,0.934991073131607,1.0,1/11,1.41%,PDPN
prerank,microtubule minus-end binding (GO:0051011),-0.35889849472649393,-0.8417603207085743,0.6891385767790262,0.9348313545920174,1.0,5/13,29.31%,MACF1;TUBGCP5;NUMA1;CAMSAP1;TUBGCP6
prerank,nucleoside-triphosphatase activity (GO:0017111),0.24473084092767866,0.8415298021735654,0.7628205128205128,0.8590986679378859,1.0,25/248,8.86%,RASL12;RERG;MYH9;RND3;AGAP2;GNAZ;RAB8B;ABCD2;TOR1B;RAC3;ATAD1;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;MYO6;RAB38;GNA12;RNF112
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.34821952048300797,0.8407027506406344,0.6387755102040816,0.857349150657198,1.0,6/21,17.93%,CHRNA3;CHRNA7;GRIK2;CHRNB2;P2RX5;GLRB
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.37875950372593564,0.8384832833813688,0.6419491525423728,0.8580682544425354,1.0,1/14,1.67%,RDH5
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.26571797929965757,-0.8364416572079942,0.7312072892938497,0.9412110759594122,1.0,19/49,36.94%,ZFAND6;IKBKE;OPTN;MINDY1;WDR81;PSMD4;BABAM2;VCP;IKBKG;UBXN1;DZIP3;ABRAXAS2;MINDY2;PARP10;HDAC6;AGAP3;RAD23A;TAB2;ZRANB3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3645548427331453,-0.8360587921461858,0.6866537717601547,0.9384469665916346,1.0,6/11,26.83%,APEX2;NEIL3;RPS3;NEIL1;APLF;NTHL1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.28565936493941313,-0.8351769261109289,0.7248459958932238,0.9365451274446779,1.0,9/33,17.77%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;XRN1;PNPT1;TOE1;PNLDC1
prerank,phosphate ion binding (GO:0042301),0.4062609402240958,0.8349836189762856,0.6372950819672131,0.8610957142783315,1.0,2/10,7.42%,RPH3A;MTHFD2
prerank,channel activity (GO:0015267),-0.26524697871363934,-0.8318007087541639,0.753393665158371,0.9394174175011856,1.0,7/41,15.56%,PDPN;MCUB;TRPV4;MPV17;TMEM120B;CHRNB1;AQP11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.37726790837924307,-0.8309966615981711,0.698292220113852,0.9373784642817857,1.0,1/10,0.43%,DPYSL3
prerank,hormone activity (GO:0005179),-0.25012673037179506,-0.8306013868154845,0.783410138248848,0.9345509370234423,1.0,10/54,23.79%,IGF1;METRNL;CCL25;PTHLH;EDN3;AGT;PPY;GNRH1;AGRP;PENK
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.33533193519030274,0.8301128776733245,0.6220472440944882,0.8665373169983299,1.0,6/24,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC17;ZDHHC21;ZDHHC23
prerank,cytokine receptor activity (GO:0004896),0.27868145432459623,0.8299931239347005,0.7037037037037037,0.8635190194672435,1.0,10/83,8.74%,IL15RA;IL1RL2;IL17RD;GFRA2;CCRL2;IL2RA;IL12RB1;ACKR2;CCR9;OSMR
prerank,CXCR chemokine receptor binding (GO:0045236),0.39612190595058927,0.828481300336301,0.6445783132530121,0.8629914723833585,1.0,3/11,12.77%,CXCL10;CXCL5;YARS1
prerank,hexosaminidase activity (GO:0015929),0.38818016289208634,0.8280704706636196,0.6252723311546841,0.860561907467425,1.0,2/12,2.63%,CEMIP2;HYAL4
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3293728928567969,-0.8198138959304148,0.7092337917485265,0.9508788109677264,1.0,5/16,17.21%,SLC22A4;SLC25A17;SLC22A5;SLC22A2;SLC25A26
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4047822578444247,0.8191256370787496,0.6460554371002132,0.872688537894235,1.0,3/10,17.43%,DCLRE1B;TATDN1;APEX1
prerank,anion:anion antiporter activity (GO:0015301),-0.3249857456371704,-0.8188321433414759,0.7398373983739838,0.9490529669846534,1.0,3/17,8.76%,SLC26A7;SLC26A2;SLC25A4
prerank,glutathione transferase activity (GO:0004364),-0.29425276932992306,-0.8141548774260942,0.7309941520467836,0.9534073785947066,1.0,5/23,14.23%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2
prerank,phosphatase activator activity (GO:0019211),-0.3333092749948128,-0.8138080694493638,0.7320388349514563,0.950495721250554,1.0,4/14,18.58%,CALM2;FRS2;CALM1;PPP2R5C
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3071100588231088,0.8114538799384977,0.6880733944954128,0.8827673558576178,1.0,4/38,3.58%,PIK3R1;NCK2;LDLRAP1;SH2B3
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3190874661172256,0.8103185998613525,0.6893203883495146,0.8814834573928174,1.0,7/31,10.87%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,deubiquitinase activity (GO:0101005),-0.23139819025399894,-0.8080394186388133,0.8679245283018868,0.9568791051518984,1.0,15/88,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;MINDY1;USP49;MPND
prerank,mRNA 3'-UTR binding (GO:0003730),-0.23020301093920875,-0.8051741766324081,0.8567567567567568,0.9581638178437991,1.0,21/79,19.27%,CELF2;RBMS2;LARP4B;DDX5;RPL41;CPEB2;IGF2BP2;ZC3H12A;PUM1;CPEB3;YBX3;LARP1;AUH;GEMIN5;FXR2;ELAVL1;RNF40;RPS7;CSDC2;ZFP36L2;PABPC4L
prerank,alkali metal ion binding (GO:0031420),0.36923224642050856,0.8049650835331211,0.6503067484662577,0.8873738842185843,1.0,1/13,1.22%,ATP1A2
prerank,hormone receptor binding (GO:0051427),0.3648694372259747,0.8041327727064299,0.6673640167364017,0.8855049411520092,1.0,3/14,7.65%,JAK1;CCK;NCOA6
prerank,receptor tyrosine kinase binding (GO:0030971),0.28274934599438517,0.8023001948595914,0.7289377289377289,0.8857276063843031,1.0,10/56,11.02%,PIK3R1;NRG1;SH2B3;NRG3;PITPNM2;SOCS5;IRS1;SHC4;BLNK;CBLB
prerank,N-acetyltransferase activity (GO:0008080),-0.3102682990505794,-0.8007985126593393,0.7401129943502824,0.9619441006983198,1.0,11/19,44.91%,KAT2B;NAT10;SAT1;NAA80;NAT2;NAT14;NAA10;AANAT;NAT8;NAT1;SMARCE1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.38490733498880314,0.8007633354039818,0.6714876033057852,0.8850730790452486,1.0,3/10,8.59%,HEXIM1;CDKN1A;INCA1
prerank,microtubule motor activity (GO:0003777),0.2916275299901056,0.8004739161240554,0.7313974591651543,0.8823978989980492,1.0,12/51,15.94%,STARD9;KIF26B;DYNC1I2;KIF3A;KIF20A;KIF5C;KIF3C;APPBP2;KIF21A;KIFC2;KIF6;KIF7
prerank,receptor antagonist activity (GO:0048019),-0.3094580024966751,-0.7986290110186727,0.7417475728155339,0.96197621186025,1.0,1/17,1.79%,DKK3
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.23007644127638827,-0.7944886526007257,0.868632707774799,0.9650568774582275,1.0,14/83,13.63%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP35;USP11;USP5;USP49;MPND
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35806625457904523,0.7930351377914868,0.6659142212189616,0.8918300692231753,1.0,2/14,4.36%,BLVRB;DHFR
prerank,deoxyribonuclease activity (GO:0004536),-0.3262311326314035,-0.7908317426725004,0.7471698113207547,0.967493863148205,1.0,6/14,26.31%,ERCC5;DNASE1L1;NME1;DFFB;RPS3;APLF
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2717750065934826,-0.7889959185737639,0.7790927021696252,0.966729789098337,1.0,4/30,7.95%,CAST;GAS6;BIRC3;CST3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.335647017043155,-0.7874035198860901,0.752,0.9658912452731891,1.0,6/13,27.19%,PLPP3;PLPP1;LPIN3;PLPP4;PLPPR4;PLPP2
prerank,transcription corepressor binding (GO:0001222),0.3113679474010648,0.7868172451721835,0.7156308851224106,0.8986334965919878,1.0,3/27,5.75%,RORA;PER2;CNOT2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3167042722215644,-0.7864743029679554,0.7243346007604563,0.9639469855190095,1.0,8/16,40.14%,PIR;ALOX12;CDO1;HGD;ALOXE3;HAAO;ALOX5;ADI1
prerank,retinoid X receptor binding (GO:0046965),0.3690575428635682,0.7863749488184075,0.6842105263157895,0.8961483937864382,1.0,3/11,7.65%,TACC1;ARID5A;NCOA6
prerank,NF-kappaB binding (GO:0051059),-0.2806741266608163,-0.7765070700809504,0.8132530120481928,0.9760242515232542,1.0,7/24,22.84%,ANXA4;HDAC1;RELA;TAF4B;NFKBIA;CDK5RAP3;SETD6
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2429105023295731,-0.7764078600687386,0.8321995464852607,0.9727279179802113,1.0,14/49,17.09%,MPPED2;PTPRJ;DUSP12;PPP1CB;SAMHD1;DUSP16;PXYLP1;EPHX2;PGAM5;PGP;SMPDL3A;DUSP10;DUSP23;LHPP
prerank,lipid phosphatase activity (GO:0042577),-0.31834332774307533,-0.7759011446421747,0.7547169811320755,0.9700893760649723,1.0,6/14,27.19%,PLPP3;PLPP1;EPHX2;INPP5K;PLPPR4;PLPP2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3272974624239432,-0.7729565727784946,0.7403846153846154,0.9711951789933178,1.0,1/13,2.48%,AGPAT4
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3719067279783458,0.7727133693167159,0.6759656652360515,0.9150157076840452,1.0,2/10,8.23%,HADHB;ECI1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.25496867403999285,-0.7694330907282217,0.8043478260869565,0.9730908772672858,1.0,19/34,40.84%,SMYD3;SETD7;KMT5A;EHMT1;EZH2;SETDB1;ETFBKMT;SETD6;SETD4;CAMKMT;DOT1L;EEF1AKMT3;EEF2KMT;METTL21C;KMT2E;VCPKMT;EEF1AKMT4;N6AMT1;SMYD2
prerank,1-phosphatidylinositol binding (GO:0005545),0.34237337416997893,0.7672995262986697,0.7028824833702882,0.9200682607116286,1.0,3/15,5.89%,SCARB1;EPB41;WDFY3
prerank,CoA-ligase activity (GO:0016405),-0.3160467682356835,-0.7662005160218941,0.7935606060606061,0.9746092601863665,1.0,1/14,2.17%,ACSS3
prerank,lysine N-methyltransferase activity (GO:0016278),-0.2883228631332782,-0.7654960223338378,0.7683397683397684,0.9722897538178299,1.0,12/20,40.84%,SETD7;KMT5A;EHMT1;ETFBKMT;SETD6;SETD4;EEF1AKMT3;EEF2KMT;METTL21C;VCPKMT;EEF1AKMT4;SMYD2
prerank,DNA replication origin binding (GO:0003688),0.31374315109463746,0.764347998129046,0.7436893203883496,0.9216359330373691,1.0,6/23,17.60%,KAT7;MCM6;MCM7;MCM2;ORC4;DDX11
prerank,phospholipase A2 activity (GO:0004623),-0.27702079569159166,-0.762437160611105,0.798,0.9734056747703759,1.0,3/26,13.20%,PLA2G4A;PLA2G6;PLA2G15
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.2221956243418624,-0.7623052090739995,0.9032258064516129,0.9701838498516928,1.0,12/75,16.59%,ABCC4;DHRS3;CRYL1;SORD;ME1;DHDH;BDH1;PGD;ADH1A;BDH2;AKR1A1;HSD17B7
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3362784457463553,-0.7610981783092452,0.8027079303675049,0.968563074201758,1.0,3/12,11.28%,SLC6A6;SLC38A5;SLC3A2
prerank,solute:sodium symporter activity (GO:0015370),-0.27348223220616247,-0.7607508493055051,0.8252032520325203,0.9656721968871349,1.0,3/27,9.26%,SLC4A10;SLC20A2;SLC5A6
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.2953899777542667,0.758709647503784,0.7355212355212355,0.9272836305700541,1.0,9/33,14.06%,NCOA3;CCAR2;TBP;RPRD1B;DRAP1;CTR9;HNRNPU;URI1;UVSSA
prerank,ubiquitin-protein transferase activity (GO:0004842),0.21477469077501682,0.7565762822289259,0.9418316831683168,0.9272887120567785,1.0,67/346,16.36%,NEDD4L;TNFAIP1;DTX3;UBR1;HECW2;BTRC;TRIM9;RNF150;CUL3;RBX1;TRAF5;PELI2;SIAH2;MYLIP;TRIM43;TRIM62;UBE2QL1;CBLL1;UBE2E3;NEURL3;NEURL1B;RCHY1;UBR3;HACE1;UBE2J2;TRAF3;VPS18;UBE2E1;SIAH3;MIB2;RNF25;KCTD13;FBXO24;RNF112;HECW1;UBE2G1;BIRC6;VPS11;RLIM;TSPAN17;CNOT4;AKTIP;CBLB;TRIM2;PPIL2;UBE3A;UBR2;RNF121;PPP1R11;RNF114;TRAF6;RMND5B;TRAF2;KLHL13;TRIM45;LMO7;ARIH1;ZFP91;RNF103-CHMP3;PEX12;RNF138;ZNRF2;TRIM37;ERCC8;NFX1;RNF6;RNF166
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.29367652424653135,0.7552271254454288,0.75390625,0.92614725728941,1.0,7/34,10.87%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,ATPase regulator activity (GO:0060590),-0.251885536965365,-0.754799419661017,0.8530066815144766,0.9708989855214585,1.0,12/38,22.01%,ATP1B3;FNIP1;BAG3;TOR1AIP1;DNAJB2;DNAJC24;PFN1;DNAJB6;DNAJC15;DNAJC10;BAG2;PLN
prerank,ubiquitin protein ligase binding (GO:0031625),0.2186436708371328,0.7532350912198633,0.922077922077922,0.9258920996299997,1.0,38/254,12.06%,GLMN;VCL;FZD6;USP25;PRR5L;PTPN22;CUL3;RBX1;ABI2;TRAF5;JAK1;TRIB2;FAF2;SCN5A;MAGEC2;UCHL1;SPOPL;PRKAR2B;YWHAZ;UBE2J2;TRAF3;BLZF1;CDKN1A;GPR37;PRKAR2A;SLF2;UBE2G1;DET1;NKD2;NEK6;PRKAR1A;OTUB1;AXIN2;RB1;GPI;NLK;APC;SPOP
prerank,N-methyltransferase activity (GO:0008170),0.31719753259957845,0.7528510185195695,0.7270833333333333,0.9232234319364558,1.0,9/20,22.52%,TRMT1;RNMT;TRMT11;PRMT1;SETD3;METTL18;TFB2M;TRMT1L;DIMT1
prerank,four-way junction DNA binding (GO:0000400),-0.29993632722278796,-0.7511764823013025,0.795131845841785,0.9724646080191,1.0,11/17,44.16%,RAD51B;HMGB2;RAD51C;MSH6;FANCM;ABL1;WRN;RAD51D;HMGB3;GEN1;YY1
prerank,Hsp90 protein binding (GO:0051879),0.2915225686348362,0.7511258460632967,0.7348484848484849,0.9226227255366354,1.0,1/33,0.64%,SLC12A2
prerank,exonuclease activity (GO:0004527),-0.24103380096078306,-0.749026102413446,0.8708240534521158,0.972010719592999,1.0,10/46,15.38%,ENPP1;CNOT7;ENPP3;DCLRE1C;REXO4;ZC3H12A;APEX2;ISG20L2;RAD50;EXOSC5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.2736960351485471,-0.7476547171672014,0.8198757763975155,0.9705769266896694,1.0,4/22,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,histone methyltransferase binding (GO:1990226),-0.3249397385473804,-0.7460357218627705,0.7883895131086143,0.9694865847379617,1.0,1/11,1.65%,LCOR
prerank,RNA cap binding (GO:0000339),-0.3003730523756273,-0.7453133539421681,0.8082706766917294,0.9672198299096888,1.0,5/16,18.29%,CYFIP2;EIF4A1;LARP1;GEMIN5;EIF4E2
prerank,kinase inhibitor activity (GO:0019210),0.292543816240811,0.7452629354373974,0.7889908256880734,0.9281665108283985,1.0,6/33,10.76%,SPRY4;HEXIM1;SNCA;TAOK3;CDKN1A;PRKRIP1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.32656382577181364,0.7413180737832356,0.7094188376753507,0.9309659171662238,1.0,7/15,22.43%,KMT2B;SETMAR;SETD3;KMT2A;KMT2D;WDR5;SETD1A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.33409868298424916,-0.74077262799291,0.7977941176470589,0.9697552387948214,1.0,1/10,1.07%,B4GALT1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.27032549045585036,-0.7392484441873893,0.8258317025440313,0.9685081169132048,1.0,2/25,1.69%,EFEMP1;TGFA
prerank,acid-thiol ligase activity (GO:0016878),-0.3137654839365023,-0.7380089512837269,0.8022813688212928,0.9669648547218354,1.0,1/13,2.17%,ACSS3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3259935692666944,0.737332319126085,0.7199170124481328,0.9334962461025877,1.0,4/17,10.72%,BAAT;ACOT12;PPT1;ACOT2
prerank,GABA receptor binding (GO:0050811),0.34148391138713474,0.736971054742887,0.748314606741573,0.9308698070471132,1.0,6/11,22.03%,PLCL2;TRAK1;TRAK2;JAKMIP1;GABARAP;GABARAPL2
prerank,Notch binding (GO:0005112),0.30662050256466544,0.7364238662867194,0.7925636007827789,0.9285094382864074,1.0,4/22,4.35%,DLL3;CHAC1;CUL3;DNER
prerank,single-stranded DNA helicase activity (GO:0017116),0.3204288297629494,0.736325153038881,0.7366336633663366,0.9255193608437902,1.0,5/19,16.87%,MCM6;WRNIP1;MCM7;MCM2;PIF1
prerank,endopeptidase activator activity (GO:0061133),-0.3330637065302336,-0.7358690132773121,0.7881040892193308,0.9663952132555998,1.0,6/10,43.84%,PSME2;PSME3;VSIR;APH1A;PSENEN;PSMD14
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2733069563061457,-0.7339734033432029,0.8408163265306122,0.965579652156716,1.0,3/21,9.30%,FGF1;KL;FRS2
prerank,phosphotyrosine residue binding (GO:0001784),0.288661847023839,0.7335941505780716,0.7587476979742173,0.9261609370257685,1.0,3/37,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,damaged DNA binding (GO:0003684),0.2785597677382649,0.7278662294684902,0.803921568627451,0.9310675641653455,1.0,17/44,23.22%,DCLRE1B;FANCG;ERCC4;RAD1;AUNIP;EP300;XPC;SMC6;RPA2;APEX1;SDE2;DDB2;MPG;CREBBP;XRCC1;PNKP;RAD18
prerank,adenylyltransferase activity (GO:0070566),-0.27801765165370546,-0.7268668121817373,0.8268839103869654,0.9710895858437867,1.0,10/21,32.79%,OAS2;KARS1;MTPAP;NMNAT1;PAPOLB;TENT4B;ABL1;OASL;GPHN;FICD
prerank,protein phosphorylated amino acid binding (GO:0045309),0.2730073982676076,0.7164084011542489,0.8155172413793104,0.9434623225410341,1.0,3/42,2.26%,PIK3R1;NCK2;LDLRAP1
prerank,lipoprotein particle receptor binding (GO:0070325),-0.2512602534570388,-0.7160132820673513,0.8837719298245614,0.9805739779255618,1.0,4/27,12.62%,APOE;HSPG2;MESD;AP2A1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.27747885233239467,0.7151451534505331,0.7855787476280834,0.9418853495949706,1.0,9/33,17.12%,NCOA3;CCAR2;RPRD1B;CTR9;MAF1;HNRNPU;URI1;UVSSA;RRN3
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.28013134221077596,-0.706330540148363,0.8445692883895131,0.9885229768576089,1.0,6/17,24.76%,LBR;DPYD;BDH2;DECR1;PTGR2;PTGR1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.2703303536129219,-0.7062296170551325,0.8864541832669323,0.985386043189352,1.0,8/22,36.94%,IKBKE;OPTN;WDR81;IKBKG;MINDY2;PARP10;TAB2;ZRANB3
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3325188401244693,0.7061044866280275,0.7875536480686696,0.950474920113211,1.0,3/10,17.45%,NAA11;NAA30;NAA15
prerank,vitamin D receptor binding (GO:0042809),0.3292803738674593,0.7037184309291362,0.7768595041322314,0.9503806448149189,1.0,9/14,28.56%,MED13;MED1;MED4;MED30;MED16;TAF7;MED14;SNW1;MED17
prerank,chemokine receptor binding (GO:0042379),-0.2349979586070875,-0.7030403876902062,0.9121621621621622,0.9856668411457863,1.0,21/35,43.90%,CXCL12;CCL15;CCL14;CCL25;CXCL16;CCL13;CCL19;CKLF;CCL2;ITCH;CX3CL1;CCL28;CCL5;CCL11;CX3CR1;CXCL1;CCL4;PF4;CCL7;PPBP;CCL8
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.33835530445699935,0.7014491889861627,0.7729166666666667,0.9500830217975299,1.0,11/11,66.19%,HCN2;CNGB1;HCN1;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.28769203147789224,-0.7010890081183385,0.8210116731517509,0.9846251373045627,1.0,1/15,2.48%,AGPAT4
prerank,ion channel inhibitor activity (GO:0008200),0.2604404664269743,0.7007481906973836,0.8764044943820225,0.9477793958524858,1.0,2/35,3.94%,NEDD4L;ITPR1
prerank,ligand-gated calcium channel activity (GO:0099604),0.2993889479693714,0.6987912480256164,0.790224032586558,0.9470652056394067,1.0,6/19,15.86%,ITPR1;RYR2;RYR3;GRIN2B;RASA3;GRIN2A
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2959941782677344,-0.6980172747512142,0.8451242829827916,0.9846178713891202,1.0,7/13,45.54%,DNASE1L1;DICER1;SLX4;EXO1;FEN1;GEN1;FAN1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3232302498505896,0.6974581941778134,0.7925311203319502,0.9456068716857272,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,endonuclease activity (GO:0004519),-0.21869287622953634,-0.6963078234346539,0.9210526315789473,0.9831820470273507,1.0,18/49,29.57%,N4BP2;NYNRIN;ERCC5;SMG6;REXO4;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;RPS3;ZC3H12B;APLF;RNASEK;NTHL1;AGO2;ENDOU
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.29843874164990286,-0.6954633486083939,0.8342541436464088,0.980830058696018,1.0,4/12,18.29%,CYFIP2;LARP1;GEMIN5;EIF4E2
prerank,endoribonuclease activity (GO:0004521),-0.2384044502349291,-0.6925364400780336,0.9004149377593361,0.9808180462908058,1.0,17/32,37.98%,NYNRIN;SMG6;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;ZC3H12B;RNASEK;AGO2;ENDOU;EXOG;ENDOG;RIDA;CPSF3;ZC3H12D
prerank,protein phosphatase regulator activity (GO:0019888),0.24607497114520463,0.6888091280123365,0.896551724137931,0.9530557838035243,1.0,18/53,22.02%,PTN;PPP2R2A;ANKLE2;PPP1R16A;PPP2R5D;SET;PPP6R2;PPP4R4;MGAT5;CABIN1;SAG;PPP1R15A;PPP2R1A;PPP2R5B;LMTK2;CALM3;STYXL1;BOD1L1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.23840746640485416,0.6884869656806295,0.9096989966555183,0.9503063637912775,1.0,20/69,19.01%,ZDHHC14;BAAT;PLAAT1;ZDHHC1;ZDHHC2;CERS4;ZDHHC16;PLA2G4E;KAT6A;GLYAT;EP300;ZDHHC17;ZDHHC21;HHAT;AWAT2;NAA15;ZDHHC9;SOAT2;CERS6;CERS5
prerank,RNA polymerase binding (GO:0070063),0.29946869089452305,0.6842541206100567,0.7975206611570248,0.9523655323039054,1.0,4/18,11.56%,PHRF1;BIN1;TCERG1;YTHDC2
prerank,miRNA binding (GO:0035198),-0.23256101679337837,-0.6807710095680223,0.8930693069306931,0.9891290686147237,1.0,8/30,19.17%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.28945827957290327,0.676268692454995,0.834,0.9525245517019079,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,serotonin receptor activity (GO:0099589),0.28945827957290327,0.676268692454995,0.834,0.9525245517019079,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.28945827957290327,0.676268692454995,0.834,0.9525245517019079,1.0,5/22,18.01%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,Hsp70 protein binding (GO:0030544),-0.23080641390094653,-0.6758882256117362,0.906318082788671,0.9906937485478895,1.0,13/31,28.49%,HDAC8;ERN1;DNAJB2;PPEF2;PPID;DNAJC10;DNAJB12;RPS3;DNAJC2;DNAJC8;PRKN;IQCG;MVD
prerank,RNA polymerase II complex binding (GO:0000993),0.2648589724047295,0.6743972759543679,0.8458574181117534,0.9515461692967856,1.0,7/32,14.06%,NCOA3;CCAR2;RPRD1B;CTR9;HNRNPU;URI1;UVSSA
prerank,MHC protein binding (GO:0042287),-0.2621061713867274,-0.6739716063228136,0.9050279329608939,0.9893052653797519,1.0,6/20,28.08%,TAPBP;CD81;TUBB4B;TAP2;LAG3;TAP1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.23500638769715815,-0.6739066501673829,0.8904665314401623,0.9862385481962039,1.0,6/26,20.64%,CSGALNACT1;CHSY1;B3GALNT1;EXTL2;CHPF2;B3GALNT2
prerank,CoA hydrolase activity (GO:0016289),0.3006778912431104,0.6706816421541655,0.8309278350515464,0.9526177693887533,1.0,4/16,15.91%,BAAT;ACOT12;ACOT2;ACOT7
prerank,3'-5' DNA helicase activity (GO:0043138),-0.2706768243207358,-0.6680585447112032,0.8975791433891993,0.9883033741032622,1.0,9/16,34.89%,ASCC3;NAV2;RECQL;ERCC3;FANCM;WRN;MCM5;HELQ;RECQL5
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.324563133586025,0.6668750324191725,0.8,0.9537338518196742,1.0,4/10,18.20%,FUOM;RPE;GALE;GALM
prerank,solute:proton symporter activity (GO:0015295),-0.26425536285317625,-0.6637653527159598,0.8997912317327766,0.989169666528894,1.0,2/16,10.60%,SLC2A13;SLC39A8
prerank,myosin V binding (GO:0031489),0.29219990782670036,0.6617690315859635,0.8530020703933747,0.9562568550473234,1.0,2/15,6.01%,RAB39B;RAB3B
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.29434256969769557,0.6613997937493528,0.8395604395604396,0.9536715794874995,1.0,4/14,15.62%,AK8;AK7;AK5;AK4
prerank,methyltransferase activity (GO:0008168),0.2430658751128706,0.6600069323212814,0.8924731182795699,0.9520174153920061,1.0,12/46,17.92%,NSUN3;AS3MT;TRMT11;EEF1AKMT1;PRMT1;GCSH;PRMT3;PRMT7;SUV39H1;GAMT;METTL4;NSUN2
prerank,hydro-lyase activity (GO:0016836),0.24769215673712838,0.6596758746975322,0.8846846846846846,0.9494438501384129,1.0,5/41,8.23%,CA4;ACO2;HADHB;ALAD;ECI1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3085430396830287,0.6583949095791027,0.829004329004329,0.9477509232236799,1.0,4/11,20.71%,RBX1;PPIL2;STUB1;UBE4A
prerank,single-stranded DNA binding (GO:0003697),-0.18116803496969913,-0.6552020551045576,0.9814814814814815,0.9932496077625386,1.0,24/93,24.60%,SSBP2;SSBP1;RAD51B;RTF1;ERCC5;REXO4;PCBP2;SAMHD1;BRCA2;NABP1;RPA1;HMGB2;PARK7;MCMDC2;RAD52;TOP3A;NEIL3;MCM8;WBP11;RAD51;CDC45;ERCC1;RPA3;POLR2G
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2667544713458303,0.6539658755748005,0.8762886597938144,0.9494980142426732,1.0,6/24,15.63%,ITPKB;AK8;AK7;AK5;AK4;AK3
prerank,tRNA binding (GO:0000049),-0.20735831182490688,-0.6534489438217712,0.954233409610984,0.991546342368998,1.0,10/43,19.41%,EEF1A1;KARS1;CARS1;ELP1;SARS1;XPOT;TYW5;TRNAU1AP;TRMT10B;NAT10
prerank,dynactin binding (GO:0034452),0.297276747008281,0.6467434240312407,0.8225108225108225,0.9540241354094939,1.0,4/12,18.00%,HOOK3;BICD2;HTT;GSK3B
prerank,ribonuclease P activity (GO:0004526),-0.27343587269940994,-0.6463728534129313,0.9084380610412927,0.9939227427891991,1.0,5/11,37.73%,PRORP;RPP38;POP1;RPP21;RPP40
prerank,glycine binding (GO:0016594),0.3031232296092923,0.6411371417389703,0.845360824742268,0.9566091141540393,1.0,4/11,21.35%,GRIN2B;SRR;GLRB;GRIN1
prerank,pyridoxal phosphate binding (GO:0030170),-0.2387085480172052,-0.6379023467957148,0.935871743486974,0.997501240274954,1.0,10/20,33.11%,PYGB;OAT;CBS;AGXT;ABAT;PDXK;PNPO;PYGL;GLDC;SHMT1
prerank,growth factor activity (GO:0008083),0.2187684623094563,0.6368407143015926,0.935,0.9576964112635497,1.0,8/74,9.27%,PTN;NRG1;NRG3;FGF2;IL4;FGF10;PDGFB;JAG1
prerank,neuropeptide binding (GO:0042923),0.2701016246604489,0.6299832818904026,0.8668032786885246,0.9610350622694273,1.0,2/18,8.13%,OPRK1;GPR37
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.256705739757704,-0.6279967760684054,0.9319470699432892,1.0,1.0,6/14,25.46%,ACO1;ISCA2;RSAD2;EXO5;NDUFS1;SDHB
prerank,tRNA methyltransferase activity (GO:0008175),0.28206616675177376,0.6279603689929114,0.8469601677148847,0.9599384109727577,1.0,2/16,9.71%,TRMT5;THUMPD2
prerank,ribosomal small subunit binding (GO:0043024),-0.24280775074115196,-0.6264581551912429,0.9155206286836935,0.9995347012369651,1.0,5/17,19.05%,CPEB2;MTIF3;NME1;LARP1;EIF1B
prerank,MHC class I protein binding (GO:0042288),-0.2658889846398398,-0.6264334473488562,0.9173989455184535,0.9964758560340027,1.0,4/13,28.08%,TAPBP;TUBB4B;TAP2;TAP1
prerank,telomeric DNA binding (GO:0042162),-0.21455011072344793,-0.6257501849759356,0.946236559139785,0.9939276795619232,1.0,7/32,22.33%,SMG6;UPF3A;RPA1;RAD50;SMG5;UPF2;ACD
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.28080416759227167,0.6219888896116699,0.8789808917197452,0.9623310867011812,1.0,2/14,6.31%,OTUD5;DESI2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21240790600982243,-0.6207840844401274,0.9565217391304348,0.9942040164377269,1.0,11/34,26.39%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;PNPT1;TOE1;PNLDC1;PAN3;EXOSC7;ANGEL2
prerank,NADPH binding (GO:0070402),-0.26120172253063695,-0.6154940234670797,0.9109848484848485,0.9945595964316177,1.0,4/13,27.28%,LBR;DECR1;GRHPR;MTRR
prerank,endodeoxyribonuclease activity (GO:0004520),-0.2369953592109679,-0.6154261341586703,0.9319066147859922,0.9915725869823901,1.0,11/20,36.99%,ERCC5;DCLRE1C;RAD50;ERCC1;RPS3;APLF;EXO1;EXOG;ENDOG;ZRANB3;FEN1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2892936760096454,0.6110544900877279,0.8852097130242825,0.9682535303050481,1.0,5/11,22.11%,HNRNPA1;RPA2;TERF1;HNRNPA2B1;CTC1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.28730531258918063,0.606813512169838,0.8783185840707964,0.9685895444615908,1.0,3/11,13.88%,RDH14;DHRS13;RDH12
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2585371951530528,-0.595259174591902,0.9204339963833634,1.0,1.0,1/11,6.44%,DDAH1
prerank,regulatory RNA binding (GO:0061980),-0.19807724741609195,-0.5927316865887687,0.9748427672955975,0.9985967530475048,1.0,9/38,20.39%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1;DICER1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.19915152649534087,-0.5922401366214601,0.9790794979079498,0.9958868724211548,1.0,9/35,23.95%,MTFMT;TARS2;FTO;ELAC2;TRIT1;PTRH2;TRMT13;FTSJ1;TRMT12
prerank,CCR chemokine receptor binding (GO:0048020),-0.20758542888975412,-0.5914784224358882,0.9707112970711297,0.9932379564283522,1.0,21/28,52.69%,CCL15;CCL14;CCL25;CCL13;CCL19;CCR2;CCL2;NARS1;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13
prerank,carboxy-lyase activity (GO:0016831),-0.21443036696724815,-0.585968297845667,0.95,0.9931926556811491,1.0,5/23,22.14%,CSAD;ODC1;DDC;BCKDHA;AZIN1
prerank,nuclear import signal receptor activity (GO:0061608),0.2591749043370142,0.5853135674558089,0.8929292929292929,0.9820211642061675,1.0,4/15,20.98%,KPNA4;KPNA1;TNPO1;KPNA3
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.21051190161726002,-0.576114799029025,0.960167714884696,0.9948749937988399,1.0,2/23,5.85%,SESTD1;WIPI2
prerank,RNA methyltransferase activity (GO:0008173),0.24958694544615623,0.5744240805023427,0.9142259414225942,0.986385597968178,1.0,2/19,6.05%,FBLL1;TRMT5
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21580453394392457,0.5725680522690728,0.957169459962756,0.9846109454761803,1.0,9/40,14.67%,FBLL1;AS3MT;PCMTD2;THUMPD2;PRMT7;SETD3;METTL18;SUV39H1;GAMT
prerank,signal sequence binding (GO:0005048),-0.18773826049836115,-0.5690421449873153,0.9799107142857143,0.9949451576117572,1.0,8/35,22.63%,CEMIP;BRAP;KPNA6;NFKBIA;BABAM2;SEC61A1;NUP214;AP2M1
prerank,N-acyltransferase activity (GO:0016410),0.22449183768786116,0.5672616390317334,0.9646840148698885,0.9849050598449675,1.0,6/32,11.61%,BAAT;PLAAT1;CERS4;PLA2G4E;GLYAT;EP300
prerank,carbohydrate kinase activity (GO:0019200),-0.2510650250698147,-0.5665552488497136,0.9618320610687023,0.9930457688598606,1.0,7/11,43.50%,HK2;GNE;HK1;KHK;GALK2;POMK;HK3
prerank,histone acetyltransferase binding (GO:0035035),-0.21677785456993848,-0.5649491815004916,0.9757085020242915,0.9906362021446203,1.0,8/21,25.85%,STAT1;HIF1A;GLI3;MEF2A;SIRT2;EGR1;TRIP4;TP53
prerank,ATP hydrolysis activity (GO:0140603),0.21381543376353246,0.5642770745365187,0.9570093457943926,0.9837431515327981,1.0,10/41,16.86%,ABCD2;TOR1B;ATAD1;DDX3X;RUVBL1;ABCB10;RHOBTB3;TOR1A;CHD1L;VWA8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.19354451769291697,-0.5627684025239308,0.9808510638297873,0.9887044252511479,1.0,13/28,39.93%,EDC3;PRORP;ELAC2;DICER1;RPP38;NUDT16;POP1;AGO2;EXO1;RPP21;FEN1;RPP40;MRPL44
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22945232853979075,0.5606547866026224,0.9543726235741445,0.9827726305810728,1.0,8/27,19.10%,POLR2C;POLR3H;MED20;POLR1A;PRIM1;POLR1B;POLR3F;POLR2D
prerank,single-stranded RNA binding (GO:0003727),0.21032704008868205,0.5578862755126603,0.9724264705882353,0.9813411332818243,1.0,14/43,21.25%,ADARB2;AGO3;DDX3X;HNRNPA1;RBM7;HNRNPU;FMR1;DDX11;LACTB2;ZFR;ENDOV;POLR2D;EIF4H;PTBP1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2570901413879484,0.5499614003008311,0.9285714285714286,0.9827583930038738,1.0,3/11,17.45%,NAA11;NAA30;NAA15
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.2147614666978983,-0.5496184055000202,0.9702048417132216,0.9906031493454478,1.0,2/18,7.80%,GAS6;BIRC3
prerank,3'-5' exonuclease activity (GO:0008408),0.20197365381453555,0.5443933941750779,0.9718045112781954,0.9826571314553876,1.0,12/45,17.93%,REXO2;PAN2;XRN2;RAD1;TRIR;REV3L;EXD1;DIS3L2;TATDN1;ERI2;APEX1;USB1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.21686309818095242,0.5440168565130398,0.95929203539823,0.979923697649505,1.0,6/28,16.09%,TRAF5;TRAF3;TRAF6;TRAF2;MADD;TRIM37
prerank,transaminase activity (GO:0008483),0.24257831835189259,0.5316545322025847,0.9219712525667351,0.9829595964737506,1.0,2/11,10.85%,GOT1;PSAT1
prerank,ubiquitin binding (GO:0043130),-0.15135299607324407,-0.5261269739403218,1.0,0.9950656101655145,1.0,21/73,31.22%,SMAD3;TOM1L1;RNF185;USP5;DNAJB2;MDM2;SIRT2;NPLOC4;IKBKG;VPS28;UBE2L6;UBXN1;TOP2A;RNF19B;PRKN;NUP62;OTUB2;CXCR4;NEDD4;AUP1;HSPB1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.16629417835671423,-0.5155973650632978,0.995260663507109,0.9946652131386218,1.0,6/42,15.89%,KAT2B;CCND2;CCND3;CCNG1;CCND1;CDKN1B
prerank,pseudouridine synthase activity (GO:0009982),0.23606228026117537,0.5074270679433076,0.9552845528455285,0.9902979683245525,1.0,13/13,76.41%,TRUB1;PUS7;DKC1;RPUSD1;PUS10;PUS1;PUSL1;PUS3;RPUSD3;RPUSD2;RPUSD4;PUS7L;TRUB2
prerank,aspartic-type peptidase activity (GO:0070001),-0.22586778077226305,-0.5027413497666468,0.9700934579439252,0.9947562216372474,1.0,3/10,31.84%,BACE2;CTSD;CTSE
prerank,gamma-tubulin binding (GO:0043015),0.21211789464687497,0.4997891670734669,0.982,0.9901340973549206,1.0,6/22,19.21%,DDX3X;BRSK1;ARHGEF7;PAK1;MARK4;NDRG1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.20293195319671162,0.4947524045312792,0.9865642994241842,0.9889597658896625,1.0,7/27,19.10%,POLR2C;POLR3H;MED20;POLR1A;POLR1B;POLR3F;POLR2D
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.23341076024860313,0.49431628762041036,0.9471544715447154,0.986195307328237,1.0,12/12,76.68%,DHRS4;CRYZL1;CBR1;CRYZ;NQO1;CBR4;NQO2;ADH4;AKR1C1;AIFM2;DCXR;NDUFS7
prerank,snoRNA binding (GO:0030515),-0.16621524654399222,-0.4802591907117071,0.9960707269155207,0.9961676434041814,1.0,11/30,36.27%,NUDT4;NOP58;UTP6;BYSL;NUDT16;NUDT1;NHP2;NUDT5;IMP4;BMS1;ISG20
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.19371281477748165,-0.45056660308307217,0.9863813229571985,0.9973800637947151,1.0,3/13,24.33%,ARHGDIA;SH3BP4;RANBP1
prerank,nuclear localization sequence binding (GO:0008139),-0.17449784380762307,-0.4495812546316226,0.9919839679358717,0.9946149125498619,1.0,4/18,20.50%,BRAP;KPNA6;NFKBIA;NUP214
prerank,ribonuclease P RNA binding (GO:0033204),0.21279266838239907,0.44126672795478794,0.9863636363636363,0.9966180976221871,1.0,10/10,78.73%,POP7;POP5;RPP30;POP4;RPP25;RPP14;RPP40;RPP21;POP1;RPP38
prerank,neuropeptide hormone activity (GO:0005184),0.1881399585401095,0.4358096842401112,0.9921722113502935,0.9946413251878581,1.0,22/22,81.21%,CCK;SPX;NPY;PNOC;OXT;CORT;QRFP;HCRT;GHRH;NPPA;UCN;CALCB;NPFF;GAL;CRH;VIP;NMB;ADCYAP1;GRP;PENK;AGRP;PPY
prerank,aspartic-type endopeptidase activity (GO:0004190),0.1716366375792579,0.37767454679058493,0.9936842105263158,0.9979676800876472,1.0,12/12,82.85%,PSEN1;HM13;SPPL3;SPPL2A;BACE1;PGC;DDI2;ASPRV1;NAPSA;SPPL2B;CTSE;BACE2
